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Summary
Proteins are molecular tools which a cell expresses from specific genes, where the
protein has one or several functions. An example of a protein function can be to detect
a particular hormone, transporting itself to the nucleus and promoting transcription of
other genes, as a response to the hormone signal. These three “actions” that the protein
performs, can be narrowed down to regions inside the protein sequence. These regions
are in this thesis termed functional units. In this example, one functional unit which
recognizes the hormone, another unit which interacts with proteins that transport it to
the nucleus and another unit which interacts with a DNA-bound protein, which results
in transcription of target genes. Thus, several functional units defines the protein func-
tion. These functional units can be classified into different categories. One of these is
functional sites.
Functional sites are small linear subsequences in proteins which can be related
to biological function. Such a function may be modification sites like phosphoryla-
tion or protein-protein interactions sites like the LxCxE motif, which interacts with
retinoblastoma proteins (Rbs). The problem with these sites is that they are so short,
often not more then 3-5 amino acids in length. This implies an informatical problem
when recognizing and predicting these short sites in protein sequences, which leads to
a lot of hits and hence overprediction. The goal of the ELM project is to provide an
Internet service for information retrieval and prediction of functional sites in proteins.
The idea behind the ELM resource is to apply biological knowledge as context filters,
and remove biological meaningless predictions, and thereby reducing the overpredic-
tion problem. For example, its meaningless to predict the LxCxE motif in extracellular
proteins, since this functional site is only active inside the cell nucleus, where the Rbs
are localized.
During this thesis five functional site have been annotated into the ELM resource.
These functional sites are: LxCxE, SID, RxL, PxDLS and PxVxL.
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Norsk oversettelse av sammendrag
Proteiner er molekylære verktøy som en celle utrykker fra et gitt gen der proteinet
har en eller flere funksjoner. En biologisk kan være f.eks. å detektere et hormon i
cytoplasma, transportere seg til kjernen for å så å promotere uttrykking av andre gener,
som svar på signalet. Alle disse tre handlingene som proteinet utfører, kan snevres ned
til regioner i protein sekvensen. Disse kalles her funksjonelle enheter. En funksjonell
enhet som er i stand til å gjenkjenne hormonet, en annen som blir gjenkjent av andre
proteiner som frakter det inn til kjernen og en siste enhet som er i stand til å binde
til et annet protein som binder DNA. Dermed kan man si at flere funksjonelle enheter
definerer protein funksjonen. Disse funkjonelle enhetene kan klassifieres i forskjellige
kategorier. En av disse er funksjonelle seter.
Funksjonelle seter er små linære subsekvenser i proteiner som har en biologisk
funksjon. Dette kan være modifiseringseter som fosforylering eller peptid ligander i
protein-protein interaksjoner som for eksempel LxCxE motivet som binder til retinoblas-
toma proteiner (Rbs). Problemet med disse funksjonelle setene er at de er så korte, ofte
ikke mer en 3-5 aminosyrer lange. Dette medfører et stort informatisk problem for å
gjennkjenne og predikere disse setene i proteiner, fordi de vil ha mange treff og vil
dermed overpredikere. Målsetningen med ELM prosjektet er å lage en database for
funksjonelle seter i proteiner. Ideen bak ELM resursen er å implementere biologisk
kunnskap som kontekst filtere, for å fjerne biologisk meningsløse prediksjoner, og
dermed redusere problemet med overprediksjon. For eksempel gjør det ingen mening
i å predikere LxCxE motivet i extracellulære proteiner, siden dette setet bare er aktivt
i cellekjernen, der Rbs proteiner er lokalisert.
I løpet av denne hovedfagsoppgaven har fem funksjonelle seter blitt annotert i
ELM resursen. Disse funksjonelle setene er: LxCxE, SID, RxL, PxDLS og PxVxL.
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Definitions
Context: The surroundings or environment which makes up the prerequisites
where an event takes place.
Region: A part of, or subsequence of a protein.
Protein Unit: A region inside a protein which can perform a function in a given
context.
Secondary structure element: α- helix, β-sheet or neither
Globular Domain: A protein unit composed of more then one secondary struc-
ture element which has a spherical appearance and few conformations. Has a defined
function in vivo.
Functional Site: A protein unit composed of one secondary structure element,
where the functional important amino acids are arranged in a linear manner. Has a
defined function in vivo.
Recognition Module: A globular domain which is able to act upon a functional
site.
Non-Globular Region: A region inside a protein which has many conformations
and no distinct structure.
Annotate: The act of manually storing data in a database.
ELM instance: A single protein which contains an experimentally verified func-
tional site.
Siteseeing: Collecting ELM instances and annotating them into the ELM resource.
Homology: Two proteins are homologous if they share a common evolutionary
ancestor.
Chapter 1
Introduction
This introduction discusses functional sites from a biological and applied bioinformat-
ical perspective.
1.1 Functional units in proteins
There are many different types of proteins, ranging from structural proteins in the
cytoskeleton to secreted enzymatic proteins. They all have one thing in common: they
interact with the surrounding environment. Besides water, the surroundings consist
most often of other molecules like: other proteins, DNA, hormones and other small
organic molecules. When investigating a protein, and the following question is asked:
“Why is my protein able to recognize another molecule?”, the answer often reveals
that a region of the protein is responsible. This is often a protein unit (see definition).
Several protein units make up a modular protein, which sometimes allows a protein to
act and respond to several events at the same time or in different situations.
Globular Domains. “Protein domain” is a phrase that is often used in different re-
search areas with different meanings. For a structural biologist, a protein domain is a
unit with a distinct structure and globular appearance. For an experimentalist, a protein
domain could correspond to a protein region with a specific function. A globular do-
main (see definition) can be considered as multiple secondary structure elements that
acts as a framework for orienting several specific residues in space, and thereby defin-
1
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ing one or more biochemical environments which is responsible for a function, e.g. an
active site in an enzyme. Here domain and globular domain are used synonymously1.
Domains constitute the largest protein unit which are structured and have a glob-
ular shape, due to the presence of hydrophobic amino acids that play a central role
in protein folding and stability [179]. Metal ligands, disulfide bonds and salt bridges
are also major factors which influence domain folding and stability. The functionally
important amino acids in a globular domain are often close to each other in space, but
can be far apart in the protein sequence. Globular domains are composed of several
secondary structure elements and can therefore arrange and orient several amino acid
residues in specific positions that can perform a certain task, e.g. the Ser/His/Asp/Thr
tetrad in some serine proteases [114]. Globular domains are sometimes referred to as
a modules, reflecting genetic mobility and a particular evolutionary history [170]. A
model for the genetic mobility of domains has been proposed: exon-shuffling [72].
This exon-shuffling mechanism is thought to play a central role in in the formation
of novel compositions of modules (and novel proteins). This mechanism is also be-
lieved to explain the observation of multi-modular proteins in eukaryotes, especially
in extracellular and nuclear proteins [176, 120].
Globular domains allow proteins to perform work in the cell, such as breakdown of
nutrients, interaction with a specific DNA region or detecting signaling molecules or
functional sites. Many globular domains are recognition modules, and some of these
are shown in Fig 1.1.
Functional sites. Functional sites are short linear regions in proteins that have a spe-
cific function, and are often found in unstructured regions in proteins [180]. They are
known by several different names: functional peptide, signature motif or active pep-
tide. Here they are called functional sites. Functional sites can be divided into different
classes based on their function: modification, ligand and cleavage sites2. Modification
sites are recognized by proteins that covalently attaches or detaches molecules to the
1See Fig 1.2 for a schematic overview of different terms used here.
2The nomenclature in the ELM resource uses four classes: ligand (LIG), target (TRG), modification
(MOD) and cleavage (CLV). The target and ligand functional sites are of the same category, but are
separated due to functional differences. Where TRG are a LIG that determines sub-cellular localization
of the host protein.
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Figure 1.1: Cartoon of some recognition modules involved in signal transduction. By the definition
in this thesis, the first two rows shows recognition modules. The others are not recognition modules since
domains, nucleic acids and phospholipids are not functional sites. Adopted from [170].
sites, often with consequences for the target protein. One example is phosphorylation
that regulates the activity of a globular domain. Cleavage sites are recognized by en-
zymes that break the peptide bond between amino acids. They have a central role in
protein degradation and protein processing such as enzyme activation, turning latent
precursor proteins into their biologically active enzymes. Ligand sites are functional
sites that mediates interactions between proteins, and is a generic protein-protein in-
teraction mechanism (Fig. 1.2). Ligand sites are able to mediate interactions with
globular domains, used for example in the recruitment of co-repressors in transcrip-
tional repression. One example of such a functional site is the LxCxE functional site
which is found in several nuclear proteins which binds to the Retinoblastoma proteins
and repress transcription 3 [49].
3The Retinoblastoma proteins and the LxCxE functional site is frequently used as an example through-
out this thesis. See section 4.1 for a more detailed description about these proteins and the LxCxE func-
tional site.
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Figure 1.2: Cartoon of different terms related to functional units. The colored balls represent
globular domains. Note that functional sites occur both outside and inside of globular domains.
All three classes of functional sites mentioned above, are actually ligands to their
cognate recognition modules. After contact or proximity has been established, the site
is cleaved, modified or retain the ligand status, depending on the recognition module.
The defining feature of functional sites are that they are short, typical ranging from 4-
10 amino acids, and that they are recognized and are acted upon by a globular domain.
Borderline functional sites. Globular domains and functional sites are two funda-
mentally different classes of protein units, which may represent two extremes. There
may be additional views depending of the different definitions of globular domains and
functional sites. The leucine-zipper, are by many, considered a domain. It is not glob-
ular, the functional important residues are organized in a linear manner in a quite long
helix (~30 amino acids). For example seen in the basic helix-loop-helix leucine zippers
of Mad-Max proteins (SMART:HLH)4 [160]. The long length and the fact that leucine
zippers are not recognized by a recognition module, but instead dimerizes, make the
leucine zipper a borderline functional site. Functional sites are composed of only one
4Typewriter fonts are used to refer to annotations in the SMART, Pfam and ELM databases.
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secondary structure element, and globular domains are composed of more then one
secondary structure element. This implies that the basic helix-loop-helix leucine zip-
per may be considered a globular domain, but the leucine zipper, alone, a functional
site.
Another borderline case are trans-membrane regions in proteins. These are com-
posed of one secondary structure element and have the functionally important residues
arranged in a linear manner, but it is not recognized by a recognition module. A final
example of a borderline functional site is in the oligomerization domain of the p53
protein. See footnote 5.
Importance of context. A prerequisite for a protein unit to be functional, is that the
unit must be in its appropriate molecular environment. This environment can be for
example a sub-cellular compartment or in a preferable molecular region in a protein.
A preferable molecular region can be in a non-globular region (see Fig 1.2), where a
functional site is exposed and available to its cognate recognition module. It would
be surprising if a region in a protein carrying the LxCxE motif described above, is
functional in an extracellular environment. The functional site is taken out of context
and inserted into an alien environment where it is unable to recognize or be recognized
e.g. other protein units that it has co-evolved with. All protein units require their
appropriate context to be functional.
1.1.1 Functional units in the Src and p53 proteins
The Src protein. A good example of how different functional units define differ-
ent functional aspects of a protein function is the membrane bound tyrosine kinase
Src, which is involved in signal transduction [143]. Tyrosine phosphorylation is a
central mechanism in the regulation of a variety of biological processes such as cell
proliferation, migration, differentiation and survival. Several families of receptor and
non-receptor tyrosine kinases control these events by catalyzing the transfer of phos-
phate from ATP to a tyrosine residue of specific cell protein targets. The Src tyrosine
kinase is composed of several protein units, as shown in Fig 1.3. When the SH2 lig-
and (functional site and “D” in figure) is phosphorylated, it binds to the SH2 domain,
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leading to inactivation and inhibition of the Src tyrosine kinase [169]. A second func-
tional site (“B” in figure) resides in a linker between the SH2 and SH3 domains. This
site acts as a ligand to to the SH3 domain in the inactive form of the Src protein [92].
Hence, three functional sites are involved in the regulation and inactivation of the pro-
tein. Phosphorylation of the tyrosine residue, the phosphorylated tyrosine acts as a
ligand, and the SH3 ligand in the so-called linker region between the SH2 and kinase
domains. In addition, the protein has an N-terminal myristoylation site (“A” in figure),
which is recognized for attachment of a myristoyl molecule anchors the protein to the
membrane [140].
Figure 1.3: Functional units in the Src tyrosine kinase. Top, a cartoon showing the functional units
in the Src tyrosine kinase. The domains predicted by SMART and four functional sites. A: myristoylation
site, B: SH3 ligand, C: Auto phosphorylation site and D: CSK phosphorylation site & SH2 ligand. Below,
active form (left) and its inactive form (right). Below picture adopted and modified from “Molecule of
the Month”, Protein Data Bank.
The p53 protein. Another example of how different functional units act together is
in the human p53 protein [47]. The p53 protein is probably one of the most studied
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proteins, due to the close relationship between a dysfunctional p53 and cancer [91].
The concentration of p53 in normal cells is very low, but is increased as a response
to cellular stress such as hypoxia (lack of oxygen) or DNA damage e.g. by radiation
[118]. The p53 protein consists of a large number of functional sites and two domains
(Fig. 1.4). The major function in the central DNA binding domain is to recognize
specific genomic sites with the consensus 5’-PuPuPuC(A/T)(T/A)GPyPyPy-3 [58].
The central DNA binding domain is also able to mediate a protein-protein interaction
with the BTCR domain found in the 53BP1 protein [53]. p53 binds as a tetramer,
which the oligomerization domain5 is responsible for, and promotes transcription of
genes, via requirement of the basal transcription machinery through the functional
site lig_tafII30 (Fig 1.4). Gene products of p53 promoted transcription include Bax,
Bak and PUMA, which result in apoptosis and cell death [78]. Since p53 is a suicide
protein, one would expect that expression and activation of the p53 protein needs to be
highly regulated.
The need for p53 to be regulated is reflected by the high number of different mod-
ification sites in the protein (currently 25 sites were registered in this thesis). Half of
the functional sites involved in protein-protein interactions in p53 are directly associ-
ated with an enzymatic process. The role of these sites may be to increase the time
of proximity between an enzyme and p53, thus allowing an enzyme to discriminate
between proteins and recognize its substrates.
1.1.2 Functional sites in the cell cycle and medicine
Functional sites are abundant in the cell cycle. Functional sites are important in
protein function, as seen with the Src and p53 proteins (Fig 1.3 and 1.4). But what role
do functional sites play in a larger context such as a pathway or a cellular process? Fig
1.5 shows a scheme of proteins involved in the different stages of the cell cycle. Most
protein complexes in the figure are held together by domain-domain interactions, like
that of cyclin/CDK, and most regulatory events involves functional sites. Phosphory-
lation of different proteins are very important in regulating the different stages of the
cell cycle, and are the most frequent functional sites in Fig 1.5. One example is the
5Here the oligomerization domain is called a "domain", but it is in fact a borderline functional site
where a single helix mediates the oligomer formation [146].
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lig_tafII30
lig_p300_1
LIG_MDM2
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lig_s100b
= mod_acetyl
= lig_cbp & lig_sir2
= LIG_CYCLIN
= lig_s100b
102 − 292
llig_Sin3_4
BTCR
DNA
DNA binding domain Oligomerization domain
Functional site class Functional site Function Ref.
Modification phosphorylation increased DNA affinity [9]
acetylation increased DNA affinity [96]
ubiquitination nuclear export and breakdown [133]
MOD_SUMO unclear [156]
isomerization increased DNA affinity [235]
Ligand LIG_MDM2 ubiquitination, degradation [96]
lig_tafII30 activation [98]
lig_p300_1 & _2 acetylation, activation [54]
lig_cbp acetylation, activation [155]
lig_s100b protection from modifications [185]
lig_sir2 deacetylation, repression [17]
lig_Sin3_4 deacetylation, repression [236]
LIG_CYCLIN increased phosphorylation [136]
nls nuclear import [126]
nes nuclear export [203]
Figure 1.4: Functional units in the p53 protein. The p53 protein have a high number of functional
sites, ~30, and two globular domains. A central DNA binding domain and an oligomerization domain
(both shown in pink). White squares are functional sites which acts as ligands in protein-protein inter-
actions. Circles symbolizes modification sites and are colored as followed: Blue= isomerization, Red=
phosphorylation, Yellow= acetylation, Green= ubiquitination and Dark Green= Sumoylation. Functional
sites above the string and written in upper cases, are predicted by the ELM resource.
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Figure 1.5: Functional sites in the cell cycle. Red circles represent phosphorylation, green are ubiq-
uitination sites and yellow boxes are ligand sites. Picture adopted from the KEGG database [105].
Rb protein in the lower left of Fig 1.5. Rb binds to the E2F-DP1 hetrodimer through a
domain-domain interaction [122]. Simultaneously Rb recruits repressors, like HDAC,
though a functional site (see also section 4.1) to repress transcription of genes which
are needed in the S phase of the cell cycle. To allow progression into the S phase, Rb
becomes phosphorylated (at several functional sites) by cyclin/CDK complexes (see
also section 4.3), to relieve repression and promote transcription of S-phase genes.
One could state that functional sites are required to achieve the dynamic and regula-
tory complexity seen in Fig 1.5. The cell cycle is one of numerous cellular processes.
Presumably functional sites are abundant in most cellular processes, especially in pro-
cesses where post-translational modifications are involved in e.g. cell signaling and
signal transduction [171].
Recognition module-functional site interaction in medicine. Recognition mod-
ules have been investigated as targets of drugs, to inhibit an interaction between a
recognition module and the corresponding functional site. Cancer cells are uncon-
trolled replicating cells and disturbing or inhibiting proteins important in the cell cycle
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are targets for several drugs.
An example of a recognition module which is a target for drugs, is a cyclin do-
main found in cyclin proteins. This recognition module is able to interact with pep-
tides and proteins which have the RxL functional site. This interaction is important
in the recognition and subsequent phosphorylation of cyclin/Cyclin Dependent Kinase
(CDK) substrates. Since cyclin/CDK dependent phosphorylation is an important pro-
cess in regulating the cell cycle (Fig. 1.5), inhibiting the interaction between cyclins
and RxL containing proteins, can lead to the disturbance and death of replicating can-
cer cells [149].
Another example of targeting a recognition module, is the p53 binding domain of
MDM2. MDM2 is a ubiquitin ligase which targets the p53 protein (see section 1.1.1)
for the attachment of the ubiquitin protein, leading to ubiquitin-dependent degradation
by the proteasome. A functional site in the p53 protein, the Fxx motif [211], interacts
with the recognition module “p53 binding domain” of MDM2. MDM2 is a negative
regulator of p53, and inhibiting the interaction between these two proteins may in-
crease the concentration of p53, leading to a possible proliferation arrest of cancer
cells [43].
Peptides and small organic compounds that mimic peptides and target recognition
modules are subject to intensive research to have potential applications as drugs [12].
1.2 Predicting functional units
The traditional way of predicting protein function, is to compare the whole sequence of
a protein in question with proteins of known functions, and using sequence similarity
to infer homology (see definition) and homology to infer function. The Basic Align-
ment Search Tool or BLAST [6], is the most frequently used sequence search method.
BLAST compares a query sequence with sequences in a database, and scores them
based on similarity. Domains, being the largest of the protein units, influence scoring
of BLAST significantly, while other shorter units like functional sites have a smaller
contribution on the final scoring, and are thereby often not detected and ignored.
Another approach in predicting protein function, is to identify the functional units
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which may reside in a protein sequence. Several bioinformatical approaches are avail-
able which uses scoring or probability matrices for prediction of functional units [76].
These include PSSM (Position Specific Scoring Matrices) [86] and HMM (Hidden
Markow Models) [56]. PSSM and profile HMMs are often applied to globular do-
mains [28] and HMM based methods are used in predicting trans-membrane units
[198]. These methods are, in many cases, not applicable to functional sites since they
are to short and often statistically insignificant.
Regular expressions can be applied to the identification of conserved regions in
proteins and identification of domains and functional sites. A pattern or a regular ex-
pression6 is a sequence or a set of rules that is matched against a string of text. A match
to a regular expression is binary; either the regular expression matches or it does not.
This makes it difficult to score a match against a regular expression. Functional sites
are intrinsically short and overprediction have been and still are a problem. When a
method overpredicts, usually means that the method generates many hits, and only a
fraction of the hits correspond to true positives. Although challenging, countermea-
sures can be applied to reduce the number of hits and hence reduce the overprediction
problem.
Web Resources for prediction of domains. Several online resources are dedicated
to prediction of domains in proteins and some of these are listed in table 1.1 7. Most of
these databases use profile based methods like HMM or PSSM and focus on long con-
served regions in proteins. Smaller regions, like functional sites, are more troublesome
and several strategies are used for predicting these.
Web resources for prediction of functional sites. Numerous databases exist for
prediction of functional sites (table 1.2), focusing on particular themes. The most
generic resource have been Prosite. But since functional sites are so short and difficult
to predict by sequence detection methods alone, the resource has emphasized domain
annotation instead of functional sites [180]. Presumably the main reason for this is
6In this thesis patterns are used to refer to the Prosite language, and regular expressions refer to the
POSIX regular expression syntax, see section 3.4
7This is the main focus of the resources. Additional predictions are also performed e.g. trans-
membrane and low complexity regions.
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Table 1.1: Resources for prediction of protein families and domains.
Database Short description Ref.
SMART Domains [125]
Pfam A Domains and protein families [27]
Prosite Domains, protein families and functional sites [23]
ProDom Generated from Swiss-Prot and TrEMBL [45]
TIGRFAMs Protein families [80]
PRINTS Protein families [16]
InterPro Unification of all databases above [10]
Table 1.2: Specialized resources for prediction of functional sites.
Database Short description Ref.
PredictNLS Nuclear localization signals [159]
TargetP Sub-cellular location [61]
PSORT Localization sites [161]
SignalP Cleavage sites and signal peptides [164]
NetPhos Phosphorylation sites [30]
The Sulfinator Tyrosine sulfation [152]
NetOGlyc GalNAc O-glycosylation [83]
NMT N-terminal N-myristoylation [145]
big-PI GPI Modification Sites [57]
iSPOT SH2, 14-3-3 or PDZ binding motifs [33]
ScanSite SH2, SH3, 14-3-3 and PDZ [165]
Prosite Functional sites and domains [23]
that functional sites are so short and difficult to predict in protein sequences. Prosite
have the comment “Warning: pattern with a high probability of occurrence”, to notify
the user that the prediction is not to be fully trusted.
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1.2.1 The ELM resource
As seen in the Src and p53 proteins, functional sites are an important aspect of how
proteins function and behave in the cell. Functional site are intrinsically short and
detecting these in protein sequences are prone to overprediction. The reason for this
overprediction is mainly due to the detection method, but also the false assumption that
all protein sequences are candidates to contain any given functional site. Functional
sites are only active in their appropriate cellular or molecular context. By including
the contextual information associated for each functional site, meaningless predictions
can be removed and the overprediction problem can be reduced. This is the main
motivation for the ELM resource. Take the following example: the functional site
LxCxE, see section 4.1. This functional site is only active in the nucleus in higher eu-
karyotes. This functional site can be represented as the regular expression [LI].C.E8
which has 6127 matches in Swiss-Prot and 484 matches in relevant proteins which
fulfill contextual requirements (see table 5.3). Applying contextual information for
this functional site leads to a 12 fold reduction of candidate proteins. The Eukaryotic
Linear Motif (ELM) resource aims at being a resource for prediction functional sites in
proteins, where biologists can perform relevant predictions of putative functional sites
in protein sequences and browse the collection of functional sites that are collected and
annotated. Se Figure 1.6 for flow scheme of prediction approach applied to the ELM
resource.
The ELM resource has currently three filters: taxonomic range (NCBI taxonomic
ID), sub-cellular localization (GO terms) and globular clash filter (SMART predic-
tions). Additional filters are awaiting implementation (see section 5.5).
8Regular expressions are written in typewriter fonts to distinguish them from the name of the func-
tional sites which often are consensus sequences. Name: LxCxE, regular expression:[LI].C.E
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Figure 1.6: Flow scheme of prediction strategy in the ELM resource. Top: a user submits a protein
sequence and taxonomic/cellular compartment ranges. Middle: the resource then searches for annotated
regular expressions hits in the submitted sequence. After this, the rules of each regular expression are
applied, and hits with a regular expression which does not meet the requirements of rules are removed.
Bottom: Final results. Adopted from poster by Puntervoll & Mattingsdal.
Chapter 2
Background and Aims
2.1 Background
This work started in January 2002 when the ELM resource was in its infancy. The
infrastructure of the database was ready, but lacking any annotated information on
functional sites and therefore not able to do any predictions. The first version of the
ELM server was launched in November 2002, and contained 30 annotated functional
sites. During the next 16 months 61 additional functional sites were added, bringing
the total number of annotated functional sites up to 91 (April, 2004). This thesis covers
5 of these 91 functional sites.
The ELM consortium consists of members that have various areas of biological
interest and skills like: database design, software development, siteseeing (see defi-
nition) and development of filters. The ELM consortium involves five European aca-
demic institutions and one biotechnology company: European Molecular Biology Lab-
oratory (European Molecular Biology Laboratory (EMBL), Germany), University of
Bergen (Norway), University of Dundee (Scotland), University of Rome - Tor Vergata
(Italy), BioInfo.PL (Poland) and CellZome (Germany). The focus at the University of
Bergen are protein functions in the nucleus which involve functional sites.
15
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2.2 Aims of this thesis
The main objective of this work was to collect data and annotate several nuclear func-
tional sites for the ELM resource: aim i), ii) and iii).
i) Collect as many as possible experimentally verified proteins from the literature
which describes the selected functional sites.
ii) Define regular expressions based upon the verified proteins for each functional
site.
iii) Define context rules which are associated with each functional site.
iv) Register new candidate functional sites for the ELM consortium, for future
analysis.
Chapter 3
Methods and data resources
This section is quite unconventional compared to traditional molecular biology theses
at the University of Bergen. This is due to the lack of any experimentally derived
data by the author, but instead the application of experimental data provided by the
scientific literature. There is no exact method for manually collecting, analyzing and
annotating data. Several approaches can be used, and the following chapter describes
one possible approach.
3.1 Online tools and databases
The kind of work presented here, depends on the availability of other informatical
tools and services provided by the scientific community. Following are world wide
web tools and databases which are the major sources used in gathering different types
of information regarding functional sites.
UniProt. UniProt or the Universal Protein Resource [11] is a comprehensive col-
lection of protein sequence information consisting of the protein sequence databases:
Swiss-Prot, PIR and TrEMBL [22, 26, 21]. UniProt was used as the source for retriev-
ing protein sequences, as described in 3.3.1.3.
PDB. The Research Collaboratory for Structural Bioinformatics (RCSB) is a con-
sortium that provide access to the protein data bank, or PDB, which is the main source
17
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Table 3.1: Online www tools and resources used in the siteseeing process.
Name Purpose URL
Databases
UniProt retrieving protein sequences http://www.ebi.uniprot.org/
PDB retrieving protein structures http://www.rcsb.org/pdb/
GO retrieval of GO terms http://www.geneontology.org/
MEDLINE database of abstracts from journals http://medline.cos.com/
Tools
NCBI tax. b. retrieving taxonomic ID numbers http://www.ncbi.nlm.nih.gov/Taxonomy
PubMed searching MEDLINE http://www.ncbi.nlm.nih.gov/entrez/
Google collecting information http://www.google.com
SRS searching in biological databases http://srs6.ebi.ac.uk/
BLAST taxonomic determination http://www.expasy.org/tools/blast/
ELM functional site predictions http://elm.eu.org/
ScanProsite retrieving protein ID http://us.expasy.org/tools/scanprosite/
Weblogo conservation in an alignment http://weblogo.berkeley.edu/
SMART prediction of globular domains http://smart.embl-heidelberg.de/
for 3D structures of biological macromolecules [29]. The PDB databank was used to
retrieve and study the structures of the functional sites, as described in 3.3.1.6.
GO. Gene Ontology is a database consisting of a set of defined biological terms de-
scribing how gene products behave in a cellular context [14]. GO provides biologists
with a controlled set of terms that simplifies annotation of biological data and compu-
tational analysis of databases annotated with GO terms. GO terms were assigned to
each functional site as explained in 3.3.2.2.
PubMed/MEDLINE. PubMed/MEDLINE is the main source for publications re-
garding scientific biological literature registered at the U. S. National Library of Medicine.
NCBI taxonomy browser. The NCBI taxonomic browser is a a tool at the U.S.
National Center for Biotechnology Information [225]. The NCBI taxonomic browser
was used to retrieve the NCBI taxonomic identification numbers for the taxonomic
annotation of each functional site.
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Google. Google is an Internet search engine which was very useful in collecting in-
formation not published in PubMed, like information stored in other biological databases
like FlyBase [15] or in the personal homepages of scientists.
SRS. SRS or the Sequence Retrieval System is a virtual library which allows queries
in different databases. SRS offers a user specific searches where a query may be a
protein name derived from a publication. For protein queries, the database UniProt
was used.
BLAST. BLAST is an algorithm developed as a method for rapid sequence com-
parison, and several websites offer this service, including; ExPASy, EMBL and NCBI
[7]. BLAST searches were used in determining the taxonomic distribution of each
functional site, see 3.3.2.1.
ELM. The ELM server was primarily used here to investigate if a functional site
resides inside a domain sequence. In addition the ELM server was used to predict
functional sites inside putative true positive proteins and browse other annotated func-
tional sites [180].
ScanProsite. ScanProsite is a tool which allow searches with a user defined prosite
pattern or a annotated prosite pattern in various databases. The tool was useful in
identifying a protein, where only a subsequence is known, see 3.3.1.3. ScanProsite is
a “child” of Prosite [23].
Weblogo. Weblogo is a web based application for analyzing an alignment by gener-
ating a picture where the size of the one letter code letters correspond to their frequen-
cies in an alignment [190].
SMART. SMART is a tool for prediction of domains in a protein sequence [125].
SMART was used here to explore if the functional site occur inside a domain sequence
and if some domains can be related to a functional site as an co-occurrence, see 3.3.2.3.
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Table 3.2: Offline tools used in the siteseeing process.
Name Topic
Vim visualization of regular expression hits
grep counting hits performed by elmfetch
ClustalX making and coloring of alignments
elmfetch extract subsequences from a sequence file
getseq retrieval of sequences
PyMOL visualization of protein structures
VMD visualization of protein structures
3.2 Offline tools
In table 3.3, are a description of small programs and tools used locally in siteseeing. A
Linux platform were used to run the following tools.
Vim. Vim is a Unix text editor which is used to create and edit text files. Vim was
used to navigate and visualize regular expression hits in protein sequence files, see
section 3.3.1.5.
Grep. Grep is a Unix application which is used to search an input file for lines con-
taining a match to a specified pattern. Grep was here used to count the number of hits
performed by elmfetch, see 3.3.1.8.
ClustalX. ClustalX is a graphical interface program for the ClustalW multiple se-
quence alignment program [207, 208]. ClustalX was primarily used here to color and
make a picture of an alignment of functional sites. In addition ClustalX was used to
make an alignment of homologous proteins. Often with default settings, but identity
matrix, at multiple alignment options, showed to be particular useful when aligning a
functional site in homologs proteins.
elmfetch. elmfetch is a script, written by Dr. Pål Puntervoll, which scans a protein
database, in FASTA format, for a user defined regular expression. The results are
displayed in a file describing the position of a hit in a sequence. Optional parameter
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is including flanking regions of the hit. All searches in local protein databases with
patterns were performed with elmfetch. See 3.3.1.5 and 3.3.1.8.
getseq. getseq is a script written by myself and with very good help from BioPython
cookbook [101] and a Python tutorial [214]. The program queries ExPASy online for
a FASTA sequence and prints it on the screen. The user must provide an accession
number. See appendix for code.
PyMOL. PyMOL is an modeling system, which include rendering capabilities for
making pictures of protein structures. URL: http://pymol.sourceforge.net/.
VMD. VMD is a molecular visualization program for displaying, animating, and
analyzing protein structures. URL: http://www.ks.uiuc.edu/Research/vmd/
3.3 Siteseeing
The following procedure is the approach used in annotation of all five functional sites
described here.
3.3.1 Going from individual papers to a regular expression
3.3.1.1 Identification of a functional site in the literature
A large amount of time was used in the identification of scientific publications de-
scribing an interaction1 which involves one of the five functional sites in this thesis.
Keywords describing the interaction, the name of the protein harboring the recogni-
tion module or the name of the biological process were often used as search words in
PubMed/MEDLINE. Reviews or structural publications did almost always provide a
good start for further collection of more experimental publications. If several publica-
tions described the same interaction, the most detailed publication was kept. Each pub-
lication was printed out for a more thorough examination of the experimental data used
and which region or subsequence was responsible for the interaction. The PubMed
identification number (PMID) was stored for future annotation in the ELM database.
1All functional sites in this thesis are ligands in a protein-protein interaction.
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Figure 3.1: Siteseeing. Flow scheme over the siteseeing process used in this thesis. The results of
siteseeing are; regular expression that describes the functional site, context rules that are associated with
the regular expression and annotated evidence for each ELM instance.
3.3.1.2 Determination of protein name
The collected publications from 3.3.1.1, were examined for identification of the name
of the protein containing the functional site. The names were stored separately for
future sequence retrieval.
3.3.1.3 Retrieving protein sequences
The name of the proteins containing a functional site, from section 3.3.1.2, were sub-
mitted in SRS to query and subsequent retrieval of protein sequences from the database
UniProt. The script “getseq” was also used for retrieval of protein sequences. The re-
trieved protein sequences were stored in FASTA format [172]. FASTA format was
used since it is the input format for the script “elmfetch”. All protein sequences con-
taining the same functional site were stored in the same file, e.g. the LxCxE functional
site (section 4.1) have been identified in 25 proteins, hence 25 protein sequences in
the same file. This file was subjected to analysis by elmfetch and manual inspection
in vim. In some cases it was difficult to retrieve the protein sequence. Presumably
the name of the protein in the publication differed from the name annotated in the
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database, or the protein have not been annotated at all. If a publication supplied a sub-
sequence, ScanProsite was sometimes used in the identification of the ID or accession
number of the protein.
3.3.1.4 Expand the dataset by homology
Homologs were only included if a publication suggested or showed functionality of ho-
mologs. BLAST was used to explore potential functional homologs, but often revealed
an altered functional site which differed from the experimental derived sequences.
BLAST was not used in a consistent manner mainly due to the following reasons:
1) collecting homologs from all verified proteins containing a functional site in this
thesis, a total of 97 proteins, is a considerable workload. 2) difficulty in determining
functionality e.g. if the functional site and cognate recognition module has diverged in
taxonomic lineages.
3.3.1.5 Extracting subsequences and building the alignment
The files containing the proteins in FASTA format, from section 3.3.1.3, were used
to extract subsequences containing the functional site in question. A prerequisite for
doing this is that a preliminary regular expression is available. A preliminary regular
expression is the immature regular expression which can be derived from the consen-
sus sequence or a proposed pattern in the literature. Manual inspection of each protein
sequence was necessary for further development of the regular expression. The Unix
editor, vim, was used for manual inspection of the FASTA formated protein sequence
file. Vim allows regular expression searches and corresponding hits are colored. This
approach was used to manually compare regular expression hits with reported regions
in the collected publications, and subsequent refining of the regular expression. When
a regular expression detects every verified functional site in the FASTA formated se-
quence file, the script elmfetch was used for extraction of the subsequences. The output
from elmfetch from each case can be seen in the alignments in Chapter 4, where the
output from elmfetch were visualized in ClustalX.
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3.3.1.6 Structural information
Structural data were available for all five functional sites analyzed here. The name
of the proteins containing the recognition modules were used as queries in the PDB
database. The VMD tool was used to explore the structure, and PyMOL was used
to make pictures of the functional sites. Structural information was used to refine the
regular expressions, especially in the determination of variable positions. For example,
if the structure reveals that a side chain of an amino acid is facing the solvent and not
the recognition module, this position was often given an “x” (meaning: any amino
acid is allowed to occupy this position). The importance of different positions are well
described in the corresponding publication of the structures.
3.3.1.7 Extraction of the regular expression
The regular expressions were continuously changed and refined as more information
were gathered. A good alignment of the subsequences is a very good start for the devel-
opment of good regular expression. After the generation of the alignment, from section
3.3.1.5, a Weblogo was made for easy visualization of important residues. The final
regular expression should be able to detect all experimentally verified subsequences
which have been shown to contain a functional site in question. The regular expres-
sions were manually derived form the alignments.
3.3.1.8 Evaluation of the regular expression
Regular expressions describing functional sites, are expected to overpredict as men-
tioned in section 1.2.1. But if the regular expression performs badly when exposed
to protein sequences, countermeasures could be implemented. To monitor the perfor-
mance of a regular expression, Scanprosite and elmfetch were used. Both approaches
gave the same result: the number of hits a regular expression or pattern has in a protein
database. Elmfetch was used for local searches with a regular expression in a protein
database, and grep was used to count the hits. The online tool, ScanProsite, was also
used for an online query. The regular expressions in this thesis were tested, and the
results are shown in table 4.6. One countermeasure to improve the performance of a
regular expression, was to divide one regular expression into several regular expres-
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sions based upon homologous proteins. If, for example a regular expression was de-
rived from 3 protein families, three separate regular expressions could be used instead.
Often though, overprediction could not be reduced by altering the regular expression
alone.
3.3.2 Collecting context information
3.3.2.1 Determination of taxonomic ranges
The protein(s) containing the recognition module was selected for the determination
of the taxonomic range of the functional site2. To determine this, BLAST searches
at ExPASy were performed against different taxonomic groups to see if the proteins
containing the recognition module are present in a taxonomic group in question. For
example, the Rb protein from human was used as a query against the following taxo-
nomic groups: Metazoa (multicellular animals), Viridiplantae (green plants), Saccha-
romyces cerevisiae and Plasmudium falciparum. Only the Metazoa and Viridiplantae
group showed significant hits, hence the functional range of Metazoa and Viridiplan-
tae. The NCBI taxonomic identification numbers of Metazoa and Viridiplantae were
retrieved using the NCBI taxonomic browser, and the corresponding taxonomy ID
number was kept for future annotation. This method was used the in the determination
of taxonomic ranges of all five functional sites in this thesis.
3.3.2.2 Determination of GO terms
The Gene Ontology (GO) terms are divided by the GO consortium into three different
categories: molecular function, cellular component and biological process. One or
more terms from each of these categories were manually selected to be associated
with each functional site. No systematic method was used for the determination of
GO terms. Manual navigation with the help of the GO browser, AmiGO, was used
in navigating the GO tree, and appropriate GO terms were selected. The GO terms
were selected based upon the collected knowledge of the recognition module, and not
the proteins harboring the functional site. For example, the Rb proteins repress genes
2The functional site that interacts with the Rb proteins is also found in some viruses, which do not
contain the Rb proteins. Making the deciding factor, distribution of recognition module, a bit question-
able.
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important in the S phase of the cell cycle. From this knowledge the following GO
terms were selected: cellular compartment-nucleus; molecular function-transcription
regulator and biological process-regulation of cell growth. All GO terms have a GO
identification number and these numbers were stored for future annotation into the
ELM database.
3.3.2.3 Discovering other protein units related to the functional site
A potential filter is the observed relationship a functional site has to another protein
unit. To explore this possibility the SMART resource was used to predict domains in
every protein sequence that have an experimental verified functional site. In this thesis
no functional sites were found to be strictly associated with a specific domain, but in
the case of the PxDLS functional site (see section 4.4), there is an over-representation
of DNA-binding domains in the verified proteins. This observation can not be used as a
filter, since some verified proteins do not have a DNA-binding domain, but can instead
be used as information to strengthen predictions. Other relationships can be discovered
from the biology of the functional site. This was the case of the RxL functional site
(see section 4.3), where two functional sites (ELM:LIG_CYCLIN and ELM:MOD_CDK) are
involved in the same biological process: cyclin/CDK dependent phosphorylation in the
cell cycle [204]. This information could be used as a logical rule and hence a filter.
3.3.3 Annotation into the ELM database
A graphical interface was developed by members in the ELM consortium for the an-
notation of data into the ELM database. Following is the description of what kind of
data was annotated. The following procedure was repeated for every functional site.
Before proceeding a following distinction should be mentioned. A functional site
is the abstract in vivo functional unit. An ELM is a regular expression and contextual
information tags representing a functional site. A functional site can be represented by
several ELM’s, but one ELM can only represent one functional site.
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Figure 3.2: Screen-shot from the ELM resource functional site and ELM input forms. Functional
site input form on the left. Here the name of the functional site, description and abstract were written.
To the right is the ELM input form. Here a small description of the ELM, GO terms, NCBI taxonomy
numbers and regular expression were annotated.
3.3.3.1 Functional site input
This is the first step in annotating a functional site into the ELM database. The name
and an abstract were written and stored into the database for each of the five functional
sites in this thesis, see Fig. 3.2.
3.3.3.2 ELM input
The ELM identifiers were defined for each functional site according to a ELM nomen-
clature defined by the ELM consortium. Beginning with the functional site class, fol-
lowed by site name and then a serial number. For example the entry ELM:LIG_RB,
shows that this functional site is a ligand and the name is here Rb. The name of the
functional site are here used to reflect the proteins harboring the recognition module.
If an additional functional site is showed to be a ligand to Rb proteins, this would
have the nomenclature: LIG_RB_2. Determined NCBI identification numbers, from
3.3.2.1, and selected GO term identification numbers, from 3.3.2.2, were annotated
for each functional site. The mature regular expression(s) was also annotated for each
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Figure 3.3: Screen-shot from the ELM instance input interface. First the acc. nr. / ID number of a
protein were annotated. Then the input form searches for the selected pattern in the protein sequence and
awaits conformation by the user. After conformation, appropriate experimental methods are annotated
with the corresponding PubMed identification number.
functional site.
3.3.3.3 References input
Three references were selected for each functional site to be shown on the websites.
These references were in many cases structural publications or good reviews of the
functional site or the proteins harboring the recognition module. These references aid
the users further into the scientific literature.
3.3.3.4 ELM instance input
This is the last step in the annotation of a functional site into the ELM database. This
process begins with the annotation of a protein ID or accession number from sec-
tion 3.3.1.3. The corresponding PubMed identification number, or PMID collected in
3.3.1.1 was then annotated. After this, determination of experimental method used in
the PMID was determined and annotated. This was done for every single 97 proteins
containing one of the five functional sites in this thesis. Following is a table which
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shows the most frequent methods used in the publications3. The ID in table 3.3, are
used in tables of verified proteins in Chapter 4. See Fig. 3.3. for a screen-shot of the
ELM instance input interface.
Table 3.3: Evidence codes. Evidence codes used for annotation experimental evidence.
Method Concept ID
Pull down Detection method 1
Yeast two-hybrid assay Detection method 2
Co-immunoprecipitation Detection method 3
Mutagenesis Altering a protein 4
Structure Detection method 5
Sequence similarity Bioinformatics 6
Alanine scanning Altering a protein 7
Western blot Detection method 8
Motif deletion Altering a protein 9
Sub-cellular localization Detection method 10
3.4 A brief introduction to regular expressions
Patterns. This is a brief overview of two similar ways to write patterns that are used
to detect functional sites or other sequences features in protein sequences. A pattern is
a way to describe rules that a sequence must fulfill in order to match the pattern, where
the pattern is often related to a function. For a more extensive view [70].
Prosite patterns and regular expressions. Regular expressions are a language
for matching textual patterns in strings, and is widely used in Unix and Unix like edi-
tors. The Prosite language is derived from regular expressions and has been developed
an an independent syntax for biological applications [38]. A hypothetical example of
going from a protein alignment to a regular expression representing rules which are
considered important e.g. for an biological event, is shown in Fig 3.2. The pattern is a
result of how a human or an algorithm interprets an alignment.
3This is not a comprehensive list of experimental methods in molecular biology. Instead the list is
used to show common methods and experimental approaches in the collected publications in this thesis.
Determining experimental approaches used in nearly 100 publications is difficult and annotations are
prone to human error.
30 CHAPTER 3. METHODS AND DATA RESOURCES
YYKIIKTPMD
YFKVIKHPMD
YYDIIKDPID
YYDFIKEPMD
YYEVIRSPMD
YYDHIKYPMD
YYDVVKNPMD
weblogo.berkeley.edu
0
1
2
3
4
bi
ts
N
1Y 2FY 3EKD 4HFIV 5VI 6RK 7YTSNHED 8P 9IM 10DC
Y[FY]..[IV][KR].P[MI]D
salsldkmsldkmsdlksmd
asdskd
Y−[FY]−x−x−[IV]−[KR]−x−P−[MI]−D
Figure 3.4: Example of developing a regular expression. Going first from an alignment, then iden-
tifying important residues and then describe the interpreted important residues in the form of a regular
expression or a Prosite pattern. Middle picture made with Weblogo [190].
A real example: the functional site, di Lysine ER retrieving signal. The site is
located at the C-terminus of ER type II membrane proteins and interacts with mem-
bers of the coatomaer (COP I) [8]. It can be represented as a regular expression or
a Prosite pattern, respectively; K.?K.{2,3}$ or K-x(0,1)-K-x(2,3)>. The sequences;
KKEE, KGKALA and KKRGT match the patterns, whereas KKARGT does not. One
can argue that the regular expression is easier to write and more difficult to read (for
a human) and vice versa for the Prosite pattern, but the two are variants of a powerful
tool for making rules and using these rules as a method for detecting subsequences
with putative functions. Some aspects of regular expressions are discussed in section
5.1.
Another comprehensive system for describing consensus patterns has been devel-
oped, which aim to be a “normalization of symbols and terms used to describe, accu-
rately and succinctly, the detailed interactions between residues of pairs of interacting
proteins at protein:protein (or protein:peptide) interfaces” [1]. This system is currently
not used in the ELM resource.
Chapter 4
Results
In the following chapter are the results of the siteseeing process of all five functional
sites in this thesis. Among these, three functional sites are involved in the repression of
transcription, where they act as mediators of protein-protein interactions when repres-
sor complexes are recruited to genomic targets. These genomic targets include genes
important in: embryonic development, cell growth, the cell cycle and cell homeosta-
sis. One functional site which is involved in the formation of heterochromatin and long
term transcriptional silencing of genes. The final functional site which is involved in
the post-translational modification of proteins, regulating the activity of target proteins
by phosphorylation. All have one thing in common: they are small subsequences found
in a large number of proteins which are involved in important molecular processes in
the cell.
The first five sections describe the five different functional sites analyzed in this
thesis. Each section begins with an introduction to the biology of the functional site,
then followed by a table of verified proteins containing the functional site. Then an
alignment, Weblogo and regular expression(s) based on the collected proteins. Each
section ends with comments about contextual information associated with each func-
tional site. Section 4.6 shows how the regular expressions behave when exposed to
protein sequences. Section 4.7 summarizes several new functional sites picked up dur-
ing siteseeing and their current status. See also http://www.student.uib.no/~st04295/
for browsing the annotated functional sites in this thesis.
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4.1 LxCxE
4.1.1 Introduction to Rb and the LxCxE functional site
The retinoblastoma protein (Rb) is a gene product of a tumor suppressor gene which
is found to be inactivated in some cancers. The Rb protein and its relatives, p107 and
p130, play a central role in controlling cell cycle progression from the G1 to the S
phase of the cell cycle. The Rb proteins defines the restriction point, which is a time-
point in the G1 phase where the cells are committed to enter the S phase. Prior to this
point, the cell can take alternative routes such as differentiation, senescence, or cell
death, depending on external signals received by regulatory proteins [154].
The fate of the cell in the cell cycle is determined by the phosphorylation state of
the Rb proteins. This depends on cyclins/Cyclin Dependent Kinases (CDK) and CDK
activating kinase (CAK). This control is due to the repression of the E2F transcrip-
tion factors (E2F-1 through 5), which promotes expression of several genes that are
required for the cell to enter the S phase. Some of these genes encode: cyclin A and
E, dihydrofolate dehydrogenase, c-myb and c-myc [51]. The E2F transcription factors
forms heterodimers with two transcription factors, DP-1 and DP-2, which are thought
to stabilize E2F when bound to DNA [205]. In resting cells Rb actively represses E2F,
but during the cell cycle the cell needs to express these E2F promoted gene products
and Rb becomes hyper-phosphorylated by cyclin/CDK complexes. Phosphorylation
by cyclin D/CDK4 and cyclin E/CDK2 of Rb proteins, releasing Rb and exposing
E2F. Due to their critical role in repression and control of the cell cycle, the Rb pro-
teins are targeted by several viruses which exploit the cell replication machinery by
pushing the cell into S phase, to promote viral growth and replication. This is achieved
by expressing oncoproteins that bind and inactivates Rb proteins and thus inactivate
repression similar to phosphorylation-mediated inactivation of Rb [205].
The Rb proteins have two protein-protein interaction “pockets”, which allows Rb
to be bound to E2F and a repressor (or a viral oncoprotein) simultaneously. The E2F
binding pocket is denominated the “A/B pocket”, since the interaction interface is de-
fined by two cyclin-like domains: the A and B domains. The other pocket is named
also after the domain where its located, the “B pocket”. This B-pocket has evolved into
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a location for protein-protein interaction to take place, where a common motif found
in every protein which interacts with the B-pocket of Rb proteins.
The protein-protein interaction motif found in Rb-interacting is denominated, “the
LxCxE motif”, after the pattern initially thought to be required for the interaction. Rb
mediated repression requires that both the A/B pocket and the B-pocket are intact and
functional so that Rb can dock repressors, via the B-pocket, and target repression at the
E2F promoter, via the A/B pocket. The major role of the LxCxE binding site in Rb is
to be a docking site for proteins (co-repressors or bridging proteins) that subsequently
recruit repressors like: histone deacetylase proteins, histone methyltransferases and
chromatin remodeling complexes. This results in Rb and bridging proteins like CtIP
[148] the RBP1 [117] proteins co-operate to form a repressional complexes.
4.1.2 LxCxE containing proteins
Table 4.11 on page 42, summarizes all collected experimentally verified instances that
uses the LxCxE motif in interaction with Rb proteins. From looking at the descrip-
tion column in table 4.1, it is apparent that there are many different types of pro-
teins that contain the LxCxE functional site, ranging from a ubiquitin hydrolase to a
RNA-specific adenosine deaminase. Presumably most proteins are co-repressors, like
CtIP and RBP1, which in turn recruits repressors. Fig 4.2 shows the alignment of the
LxCxE functional site and 10 additional residues on each side. Notice the diversity
of the amino acids flanking the functional site. One protein has it in the C-terminal
and another protein has it in the N-terminal. Some proteins have several proline and
glycine residues (which are expected since functional sites are thought to reside in
non-globular regions), and in contrast some are lacking flanking prolines and glycines.
There are no obvious similarity besides the motif itself.
1The table layout is repeated for all five functional sites in this thesis. ID/Acc. is the ID or accession
number from annotated proteins in databases in UniProt. The short descriptions are directly taken from
UniProt annotations. * is used to show that this is a Pfam domain clash. The numbers in the “Method”
column corresponds to evidence codes used in table 3.3.
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Figure 4.1: Structure of LxCxE motif bound to its recognition module in Rb. The LxCxE motif
in the Simian Virus 40 large T antigen protein (green cartoons) is shown bound to the retinoblastoma
protein (shown in wheat color and surface representation). In retinoblastoma, the A domain is the globular
domain on the left and the B domain is the globular domain on the right. The B domain is the recognition
module for the LxCxE motif. PDBid: 1GH6, [109].
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   E1A_ADE02/112−136 MPNLVPEVIDLTCHEAGFPPSDDED
      Q8UYK9/184−208 TYTPEFPTESLICHETIESWKNEHL
  UBP4_HUMAN/449−473 DTFHGLFKSTLVCPECAKVSVTFDP
  AC15_HUMAN/652−676 PGVGKTTTASLVCQELGYSYVELNR
  PRD2_HUMAN/300−324 PNENSVKEPEIRCDEKPEDLLEEPK
     VE7_HPV16/12−36 MLDLQPETTDLYCYEQLNDSSEEED
    RBB9_HUMAN/53−77 SIWLPFMETELHCDEKTIIIGHSSG
SN22_HUMAN/1280−1304 IIKDDAEVERLTCEEEEEKIFGRGS
      Q9WIJ4/100−124 RLYGFLDMDDLSCRELLPPEEDDDI
  RBB8_HUMAN/143−167 E
^|
NDQQHQAAELECEEDVIPDSPITA
    TALA_SV40/93−117 QWWNAFNEENLFCSEEMPSSDDEAT
      Q9Y6B2/168−187 LMVVNRLTEELGCDEIIDRE
    ELF1_HUMAN/41−65 GADILNSYAGLACVEEPNDMITESS
  II2A_MOUSE/406−430 VNCEIGNTIRLVCFELTSNADEWFL
   AHR_HUMAN/321−345 GYQFIHAADMLYCAESHIRMIKTGE
     CGD1_HUMAN/1−19 MEHQLLCCEVETIRRAYPD
  TRAL_HUMAN/515−539 EAMKKKDTEVLFCFEQFDELTLLHL
  IFI4_MOUSE/601−625 VRCEPGSKLRLVCFELTSTEDGWQL
  RBB1_HUMAN/947−971 DAMPLIGPETLVCHEVDLDDLDEKD
        RBP95/99−123 AQLDETVEALLRCHESQGELSSAPE
RBB2_HUMAN/1363−1387 VKSSSSLEPNLFCDEEIPIKSEEVV
      Q9WKM8/101−125 LGGDYSVYQDLYCDEVLSSSSTEEE
  PP71_HCMVA/206−230 PLTLVDALEQLACSDPNTYIHKTET
     HP1_DROME/51−75 TENTWEPENNLDCQDLIQQYEASRK
  POLN_RUBVT/521−545 PPWLFAERRALRCREWDFEALRARA
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Figure 4.2: Alignment of the motif from proteins containing the LxCxE motif. Alignment, Webl-
ogo and regular expression of verified proteins in table 4.1.
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4.1.3 Context rules and filters
Localization. Most proteins that interact with Rb are associated and localized in the
nucleus, but at least one protein, hsp75, is localized in the cytoplasm. The hsp75
protein has been proposed to act as a molecular chaperone for the Rb proteins, aiding
in refolding to their native state, after phosphorylation by cyclin/CDK [41]. Although
the LxCxE binding function is regulated by phosphorylation at T821 and T826 in
Rb [112], the interaction may depend on de-phosphorylation by PP1-alpha, to allow
interaction between Rb and hsp75 [184]. The interaction between these two must
therefore be limited to specific time points in the cell cycle (breakdown of the nuclear
envelope) or another special condition where the two proteins moves from their usual
compartment.
Although Rb has been shown to interact with a non-nuclear protein, hsp75, the
annotation of the LxCxE motif to the nucleus is justified by the majority of verified
proteins are localized in the nucleus, and the application of the nucleus as a filter
(Table 5.1.).
Taxonomy. The retinoblastoma proteins Rb, p130 and p107 were first found in verte-
brates, but homologs has been identified in other metazoans and plants, like C. elegans
[137], Z. mays (maize) [75], and A. thaliana [106], and in the green algae, Chlamy-
domonas [212]. Plant and metazoan Rb proteins have been shown to from repressor
complexes and are susceptible to several viral oncoproteins that utilize the LxCxE
motif, e.g. bean yellow dwarf virus and banana bunchy top virus [221], suggesting a
similar function in vivo. Although Rb has been identified in the algae Chlamydomonas,
its is unclear if the protein share function with its metazoan relatives. Retinoblastoma
binding proteins that uses the LxCxE functional site are at least found in: metazoa
(multicellular animals, Taxonomy ID: 33208), viridiplantae (green plants, Taxonomy
ID: 33090) and viruses (Taxonomy ID: 10239).
Globular clash filter. 5 of the 17 verified cases (table 4.1) have the functional site in-
side a domain: RFC1_HUMAN (SMART:AAA)2, AHR_HUMAN (SMART:PAS), II2A_MOUSE
2This refers to a SMART, Pfam or ELM entry .
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and IFI4_MOUSE (Pfam:HIN), TRAL_HUMAN (Pfam:HSP90) (results not shown).
Although the globular filter removes five true instances for the LxCxE motif, it
shows itself to be a powerful filter [180].
Molecular context and co-occurrences. The domain architecture of verified pro-
teins that uses the LxCxE functional site are diverse. There are no other co-occurrences
of protein units that can be associated with the LxCxE functional site.
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Table 4.1: Verified proteins which uses the LxCxE functional site.
Name ID/Acc.nr. Short description Length Dom. PMID Ref. Method
RBP1 RBB1_HUMAN Retinoblastoma-binding protein 1 1257 - 8414517 [117] 3
RBP2 RBB2_HUMAN Retinoblastoma-binding protein 2 1722 - 8414517 [50] 3
RFC1 RFC1_HUMAN Replication factor C large subunit 1147 yes 11336696 [173] 1
IFI2 Il2A_MOUSE Interleukin-2 receptor alpha chain precursor 445 yes* 7890747 [44] 4
IFI4 IFI4_HUMAN Double-stranded RNA-specific adenosine deaminase 640 yes* 10951565 [88] 2
UBP UBP4_HUMAN Ubiquitin carboxyl-terminal hydrolase 4 963 - 11571651 [31] 3
ELF-1 ELF1_HUMAN ETS-related transcription factor Elf-1 619 - 8493578 [219] 1
AHR AHR_HUMAN Aryl hydrocarbon receptor precursor 848 yes 10644764 [59] 2
BRM SN22_HUMAN Possible global transcription activator SNF2L2 1586 - 9326598 [209] 3
RBP95 Q9HC82 Rb-associated protein 838 - 10944455 [223] 2
HSP75 TRAL_HUMAN Heat shock protein 75 kDa 704 yes 8756626 [41] 4
BOG RBB9_HUMAN Retinoblastoma-binding protein 9 186 - 9697699 [227] 2
EID Q9Y6B2 RB-and P300-binding protein EID-1 187 - 11073990 [142] 4
Cyclin D1 CGD1_HUMAN G1/S-specific cyclin D1 295 - 7696881 [32] 2
RIZ PRD2_HUMAN PR-domain zinc finger protein 2 1719 - 7538672 [39] 4
CtIP RBB8_HUMAN Retinoblastoma-binding protein 8 897 - 10449734 [148] 2
HP1 HP1_DROME Heterochromatin protein 1 206 - 11533237 [216] 1
Viral
HPV E7 VE7_HPV16 E7 protein 98 yes* 9495340 [123] 5
BBTVDNA5 Q9WKM8 Hypothetical protein 129 - 10640570 [221] 2
NSP90 POLN_RUBVT RNA-directed RNA polymerase/helicase 2205 yes* 10073691 [68] 4
SV40 largeT TALA_SV40 Large T antigen 708 yes* 11226179 [110] 5
BYDV RepA Q8UYK9 Replication-associated protein A 264 - 10191192 [132] 2
Clink Q9WIJ4 Cell cycle link (CLINK) protein 169 - 10708410 [13] 4
A E1A E1A_ADE02 Early E1A 32 kDa protein 289 yes* 2538790 [40] 1
PP71 PP71_HCMVA 71 kDa upper matrix phosphoprotein 559 - 12612064 [104] 4
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4.2 SID
4.2.1 Introduction to Sin3 and the SID functional site
The SID (Sin3 Interacting Domain) was first found in the Mad family of transcrip-
tional repressors [19]. The Mad proteins, are members of the Myc/ Max/ Mad network
which regulates different genes involved in several aspects of cell behavior (reviewed
in [139]). This SID interacts with the PAH2 (Paired Amphipatic repeat 2) domain,
which is one of three (PAH1, PAH2 and PAH3) protein interaction domains in the
paralogs Sin3A and Sin3B in mammals. The Sin3 proteins are thought to be scaf-
fold proteins. They have multiple interaction partners and form a transcriptional re-
pressor complex called the Sin3-complex, which has a central role in Sin3-dependent
transcriptional repression in diverse cellular processes such as proliferation, differen-
tiation, apoptosis and cell fate determination. Components of this complex include
two histone deacetylase proteins (HDAC1 and HDAC2), RbAp46, RbAp48, SAP18,
SAP30 and the Sin3 protein itself (reviewed in [5]). In addition, several new compo-
nents of the Sin3 complex has recently been identified: SAP45, SAP130 and SAP180
[67].
The SID itself is an amphipatic α- helix (hydrophobic on one side and hydrophilic
on the other, in respect to the axis) and interact with a deep hydrophobic groove defined
by the PAH2 domain in Sin3B shown in Fig 4.3. The SID is found in two different pro-
tein families which repress transcription: 4 members of the Mad family and 5 members
of the sp-1 like/KLF transcription factor family. In addition, a yeast protein (UME6)
and a PHD domain containing protein (Pf1) has show to contain the a SID .
4.2.2 SID containing proteins
The proteins that have experimental evidence for the use of the SID helix in interaction
with the PAH2 domain of Sin3 are listed in table 4.2. All verified proteins are tran-
scription regulators which recruits the Sin3 repressor complex via the SID functional
site. The alignment of all SID containing proteins shows, to some extent, that the SID
shares little sequence similarity between the different proteins. Orthologs are included
due to a low number of verified proteins. The pattern was divided up into three differ-
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Figure 4.3: Structure of the SID α-helix bound to the PAH2 domain of Sin3B. The PAH2 domain of
Sin3B (colored blue and shown in cartoon and transparent surface) and the SID helix from Mad1 (green
cartoon). The important amino acid residues in the SID helix are shown in yellow sticks. PDBid: 1G1E,
[37].
ent regular expressions, due to a to weak performance of a single regular expression.
A proposal to one single regular expression is: [LMYMHFP]..[AVF]..[FYLA][LMVA].
This expression has more then one hit pr. protein in Swiss-Prot. To prevent this, the
single regular expression was divided into three different regular expressions. One
expression reflecting the Mad proteins, one expression representing the sp-1 like pro-
teins and one regular expression reflecting the unrelated proteins, TGIF, UME6 and
Pf1. This difficulty in making one single regular expression may be the result of a
poor alignment.
4.2.3 Context rules and filters
Localization. All SID containing proteins are transcription factors that are localized
in the nucleus.
Taxonomy. Proteins that uses the SID are found in H. sapiens, M. musculus and S.
cerevisiae. To investigate if the Sin3 protein is present in plants a BLAST search was
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  MNT_HUMAN/1−18 MSIETLLEAARFLEWQAQ
   MXI1_RAT/4−24 VKMINVQPMLEAAEFLERRER
  MAD_MOUSE/4−24 AVGMNIQLLLEAADYLERRER
MXI1_BRARE/20−40 TFLKNVQVLLEAASYIESAER
  MAD_HUMAN/4−24 AVRMNIQMLLEAADYLERRER
 MAD4_HUMAN/1−21 MELNSLLILLEAAEYLERRDR
 MAD4_MOUSE/1−21 MELNSLLLLLEAAEYLERRDR
 MXI1_HUMAN/4−24 VKMINVQRLLEAAEFLERRER
  MNT_MOUSE/1−18 MSIETLLEAARFLEWQAQ
 MXI1_MOUSE/4−24 VRMINVQRLLEAAEFLERRER
^|
[LIV]..[LM]L.AA.[FY]L
* *.: *:.:*
 BTE4_MOUSE/1−22 SAAVACVDYFAADVLMAISSG
KLFB_HUMAN/35−57 CSILEQTDMEAVEALVCMSSW
 KLFD_HUMAN/1−21 MAAAAYVDHFAAECLVSMSSR
 BTE1_HUMAN/1−21 MSAAAYMDFVAAQCLVSISNR
 BTE4_HUMAN/1−22 SAAVACVDYFAADVLMAISSG
 BTE1_MOUSE/1−21 MSAAAYMDFVAAQCLVSISNR
KLFA_MOUSE/28−50 WDKAEQSDFEAVEALMSMSCD
KLFA_HUMAN/29−51 NKTAEKSDFEAVEALMSMSCS
  KLFA_RAT/28−50 WDKAEQSDFEAVEALMSMSCD
KLFB_MOUSE/35−57 CSILEQTDMEAVEALVCMSSW
 KLFD_MOUSE/1−21 MAAAAYVDHFAA
^|
ECLVSMSSR
   BTE1_RAT/1−21 MSAAAYMDFVAAQCLVSISNR
[FHYM].A[AV].[VAC]L[MV].[MI]
. : :: .
    Q96QT6/199−220 PDYVQPQLRRPFELLIAAAME
 AKR_CHICK/235−259 TPPDLNQDFSGFQLLVDVALK
TGIF_HUMAN/238−262 TPPDLNQDFSGFQLLVDVALK
TGIF_MOUSE/238−262 TPPDLNQDFSGFQLLVDVALK
UME6_YEAST/511−535 SSTKLDDDLGTAAAVLSNMRS
^|
[FA].[LA][LV][LVI]..[AM]
Figure 4.4: Three alignments of the SID helix from proteins listed in table 4.2. The dataset was
divided into three groups, depending on either they belong to the mad family, the sp-1 like family or
neither. Top: MAD family. Middle: sp-1 like proteins. Bottom: The unrelated proteins Pf1, TGIF and
UME6. Weblogo is not shown.
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performed as described in 3.3.2.1. Several viridiplantae proteins showed significant
hits. Hence presuming taxonomic range of Eukaryota; Taxonomy ID: 2759
Globular clash filter. The SID has not been observed inside a domain sequence.
Co-occurrence and molecular context. Most SID containing proteins have a do-
main that has a function related to transcription. The Mad proteins have a Helix-loop-
Helix dimerization domain (SMART:HLH), sp-1 like has 3 DNA binding Zinc fingers
(SMART:ZnF_C2H2) the Tgif has a DNA binding homeo domain (SMART:HOX), and the
UME6 yeast protein has a DNA binding domain of the Gal4 family (SMART:Gal4).
The Pf1 protein has two PHD fingers (SMART:PHD) which are associated to several
functions including chromatin binding activity [181] and as a phosphoinositide recep-
tor [74].
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Table 4.2: Verified proteins which uses the SID functional site.
Name ID/Acc.nr. Short description Length Dom. PMID Ref. Method
MAD MAD_HUMAN MAX dimerizer 221 - 11101889 [201] 5
MXI1 MXI1_HUMAN MAX interacting protein 228 - 10918583 [150] 8
MNT MNT_HUMAN MAX binding protein MNT 582 - 9000049 [93] 2
MAD4 MAD4_HUMAN Max-interacting transcriptional repressor MAD4 209 - 8816491 [19] 6
TIEG1 KLFA_HUMAN Krueppel-like factor 10 480 - 11438660 [233] 1
TIEG2 KLFB_HUMAN Krueppel-like factor 11 512 - 12006497 [60] 1
BTEB3 KLFD_HUMAN Krueppel-like factor 13 288 - 11477107 [102] 1
BTEB1 BTE1_HUMAN Krueppel-like factor 9 244 - 11438660 [233] 1
BTEB4 BTE4_HUMAN Krueppel-like factor 16 252 - 11438660 [233] 1
TGIF TGIF_HUMAN 5’-TG-3’ interacting factor 272 - 11571228 [228] 8
UME6 UME6_YEAST Transcriptional regulator UME6 836 - 9150136 [103] 4
Pf1 Q96QT6 PHD zinc finger transcription factor 704 - 11390640 [230] 2
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4.3 RxL
4.3.1 Introduction to cyclin and the RxL functional site
Cyclins are a family of proteins that regulate the activity of a group of protein kinases:
the cyclin-dependent kinases (CDK) by binding and forming cyclin/CDK hetrodimers.
In addition to cyclin binding, a specific threonine residue (T161) in CDK must be
phosphorylated by CAK (CDK activating kinase), representing the final step in CDK
activation [64]. The cyclin/CDK complexes phosphorylate different proteins in or-
der to orchestrate the complex task of regulating the different stages in the cell cycle.
Each cyclin have its specific CDK binding partner(s), and both cyclin and CDKs are
expressed and degraded at different stages during the cell cycle. In humans, 8 different
CDKs and 10 different cyclins have been identified and some of the observed com-
binations are: cyclin D/CDK4/6 (G1 phase), cyclin E/CDK2 (G1/S transition), cyclin
A/CDK2 (S and G2 phase) and cyclin B / CDK1 (G2 and M phase) [153].
There are two functional sites associated with cyclin/CDK dependent phosphory-
lation: a CDK consensus phosphorylation site and a cyclin interaction site. This last
site, the Cy motif or RxL motif, has been show to interact with cyclins and thereby in-
crease the level of phosphorylation of a CDK substrate. This requires that a substrate
of a cyclin/CDK complex are in proximity of both proteins, and these two sites should
be separated by at least 12 amino acids [204]. Insertion of a RxL motif in surface
loops has been observed to increase phosphorylation of otherwise non-phosphorylated
substrates [55]. The structure of the cyclin A/CDK2 with several peptides containing
the RxL motif from proteins like p53, Rb, E2F, p107 and the inhibitor, p27, have been
solved [135]. In addition, a motif found in Xenopus cyclin B2, the RRASK motif, has
been implicated in the substrate recognition of cyclins [73], and may be a variant of
the RxL motif.
4.3.2 RxL containing proteins
The RxL functional site has been identified in several eukaryotic proteins (table 4.3).
The majority of proteins in table 4.3 are transcription factors and co-repressors, like
E2F, p53 and Rb. In addition, several inhibitors of cyclin/CDK activity uses the motif
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Figure 4.5: Structure of a RxL containing peptide bound to a cyclin/CDK hetrodimer. Cyclin
A (blue cartoon)/ CDK2 (red cartoon) hetrodimer bound to a RxL containing peptide derived from E2F
(backbone shown in green sticks). The amino acid residues defining the functional site are shown in
yellow sticks. PDBid: 1H24, [135].
in interaction with cyclin, like p21, p27 and roughex. The alignment of the motif
is shown in figure 4.6. At first glance only the consensus (RK)xL are common to all
sequences. But further analysis shows hydrophobic residues are common in the first or
second residue after the (RK)xL consensus sequence. Structural data obtained by [135]
shows this hydrophobic residue does indeed contribute to significant van der Waals
interaction between the peptide and cyclin A. These have therefore been included in
the regular expression, which then becomes [RL].L.{0,1}[FYLIVMP], where .{0,1}
means that any are allowed to occupy this position, but none is required. Also notice
the frequency of proline and glycine residues flanking the functional site.
Different cyclins/CDKs presumably have different substrates. It is thus possible
that the RxL motif is the determinant for specificity. Future work will hopefully de-
termine if the RxL functional site should be divided into several functional sites, each
with their specific cyclin binding partner.
4.3.3 Context rules and filters
Localization. The cellular localization of cyclin/CDK complexes are diverse. Some
cyclin/CDK complexes are primarily localized to the nucleus, other to the cytoplasm
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: *
    RB_HUMAN/863−885 AEGSNPPKPLKKLRFDIEGSDEA
     H10_HUMAN/61−84 NADSQIKLSIKRLVTTGVLKQTK
   P53_HUMAN/371−393 SKKGQSTSRHKKLMFKTEGPDSD
      Q9WTQ5/490−513 ERIKVQGSPLKKLFSSSGLKKLS
  HIRA_HUMAN/619−644 PLAKASSLSKRKLELEVETVEKK
  E2F3_HUMAN/124−149 SGGGGGPPAKRRLELGESGHQYL
    CDNC_HUMAN/21−45 FPVLVRTSACRSLFGPVDHEELS
CUT1_HUMAN/1291−1315 WFHNYRSRIRRELFIEEIQAGSQ
  CDN1_HUMAN/145−164 TSMTDFYHSKRRLIFSKRKP
  RBL1_HUMAN/648−672 YSSPTAGSAKRRLFGEDPPK
^|
EML
  RBL2_HUMAN/670−694 YSSPPASTTRRRLFVENDSPSDG
    CDNB_HUMAN/20−44 QAEHPKPSACRNLFGPVDHEELT
  MPI1_HUMAN/324−348 TIENILDNDPRDLIGDFSKGYLF
   E2F1_HUMAN/80−105 RPALGRPPVKRRLDLETDHQYLA
   E2F2_HUMAN/77−102 CLPAGRLPAKRKLDLEGIGRPVV
      O14731/474−490 PRGSFPSFEPRNLLSMFEDTLDP
         Q13352/5−15 MPVKRSLKLDGLLEENS
      Q99741/182−205 GPPHSHTLKGRRLVFDNQLTIKS
      Q8UWJ8/382−405 QVAKLTGHSYRVLYLAMSPDGEA
   RUX_DROME/238−259 TPPTARRCVRRTLFTEENTQKEK
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Figure 4.6: Alignment of the verified proteins carrying the RxL functional site listed in table 4.3.
Alignment, Weblogo and regular expression of all experimentally verified proteins which uses the RxL
motif.
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and yet other shuttle in and out of the nucleus. Localization of cyclin/CDK complexes
are reviewed in [229]. The major cytoplasmic cyclin/CDK proteins are the cyclin
B1 and B2/CDK1 (formerly called Cdc2) complexes. In addition, cyclin D1/CDK2/4
are exported from the nucleus to the cytoplasm during the G1 to S transition. The
activity of cyclin/CDK complexes and the RxL motif is thus limited to the nucleus and
cytoplasm.
Taxonomy. Cyclins are found in all eukaryotic organisms, and presumably so is the
RxL motif, hence the annotation Eukaryota: Taxonomy ID: 2759. The RxL functional
site has, however, not yet been identified in lower eukaryotes.
Globular clash filter. The non-globular filter rules out two known proteins, the
(CDP)/Cux transcription factor and the Cdh1 protein. The site in (CDP)/Cux are in-
side a homeo domain (SMART:HOX) and is located at the very end of the domain, still
suggesting accessibility. In the other protein, Cdh1, is found to be in the middle of a
WD40 repeat domain (SMART:WD40) (results not shown).
Molecular context and co-occurrences. As mentioned earlier, a substrate for phos-
phorylation of a cyclin/CDK complex presumably should have two functional sites:
the RxL motif and the CDK phosphorylation consensus motif, (ST)Px(KR). Since
both are annotated in the ELM resource, there is an opportunity that they should be
associated with one another and thereby provide a co-occurrence filter.
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Table 4.3: Verified proteins which uses the RxL functional site.
Name ID/Acc. Short description Length Dom. PMID Ref. Method
Rb RB_HUMAN Retinoblastoma-associated protein 928 - 9891042 [3] 9
p107 RBL1_HUMAN Retinoblastoma-like protein 1 1068 - 11884610 [124] 4
p130 RBL2_HUMAN Retinoblastoma-like protein 2 1139 - 11884610 [84] 6
E2F1 E2F1_HUMAN Transcription factor E2F1 437 - 9199321 [55] 1
E2F2 E2F2_HUMAN Transcription factor E2F2 437 - 9199321 [55] 6
E2F3 E2F3_HUMAN Transcription factor E2F3 465 - 9199321 [55] 6
HIRA HIRA_HUMAN TUP1 like enhancer of split protein 1 1078 - 11238922 [81] 3
Cux CUT1_HUMAN CCAAT displacement protein 1505 - 11584018 [187] 1
Myt1 O14731 Membrane-associated kinase 499 - 10373560 [131] 9
p53 P53_HUMAN Cellular tumor antigen p53 393 yes* 10884347 [138] 3
SSeckS Q9WTQ5 PKC binding protein SSECKS 1684 - 10982843 [127] 4
Roughex RUX_DROME Cell cycle negative regulator roughex 335 - 11027291 [18] 2
b3-endonexin Q13352 Beta 3-endonexin 170 - 10673397 [166] 1
CDC6 Q99741 CDC6-related protein 560 - 9889196 [175] 1
cdc25a MPI1_HUMAN M-phase inducer phosphatase 1 523 - 9234691 [186] 4
p202 Q13632 NPAT protein 1175 - 10995387 [141] 10
p21 CDN1_HUMAN Cyclin-dependent kinase inhibitor 1 164 yes* 11438644 [42] 4
p27 CDNB_HUMAN Cyclin-dependent kinase inhibitor 1B 198 yes* 9488039 [4] 4
p57 CDNC_HUMAN Cyclin-dependent kinase inhibitor 1C 316 yes* 10713702 [85] 9
Cdh1 Q9UI96 Fizzy-related protein homolog 453 yes 11340163 [199] 8
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4.4 PxDLS
4.4.1 Introduction to CtBP and the PxDLS functional site
The CtBP, or C-terminal Binding Protein, was first discovered as an interaction part-
ner of the viral protein E1A, expressed by all human adenoviruses. Further analysis
showed that only a small subsequence in the viral protein was sufficient for interaction
with CtBP [188]. After this discovery several eukaryotic proteins involved in tran-
scriptional repression has been identified to interact with CtBP proteins via this small
motif including the mouse krüppel-like factor (BKLF) [210]. In vertebrates two par-
alogs of CtBP have been identified: CtBP1 and CtBP2. These are able to form homo-
and heterodimers and thereby may be able to bind two motif containing proteins si-
multaneously [193]. The CtBP binding proteins which uses the motif can be divided
into two groups: one group are proteins associated with DNA (direct or indirect DNA
binding), or the other group of proteins associated with transcriptional repression (hi-
stone deacetylase proteins type II, polycomb 2). This suggests that the CtBP proteins
acts as a bridge, recruiting repressors to DNA bound proteins.
The CtBP proteins share a high degree of similarity to a group of dehydroge-
nases called, 2-hydroxy dehydrogenases. The interaction between CtBP and a motif-
containing protein has been shown to depend on NAD+/NADH binding [115].
4.4.2 PxDLS containing proteins
A large number of PxDLS containing proteins have been identified and are listed in
Table 4.4. The verified proteins can be roughly be divided into two groups: either
DNA bound transcription factors or repressors like the histone deacetylase proteins
(which may not be surprising since the role of CtBP is to recruit repressors to tran-
scription regulators). Following is the alignment of the subsequences of the proteins
in table 4.4. Firstly the abundance of proline and glycine is obvious and suggests that
these functional sites reside in non-globular regions. The first residue of the motif is a
proline or glycine, followed by mostly hydrophobic residues and two cases where glu-
tamate is present. In the middle of the functional site is there preference for the acidic
amino acids glutamate and aspertate but two instances each of aspergine and serine
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Figure 4.7: Structure of the PxDLS motif bound to the CtBP protein from rat. The CtBP/BARS
protein (gray cartoon) bound to a PxDLS containing peptide (green sticks) and NADH (red sticks). The
important residues in the PxDLS containing peptide are displayed in yellow sticks. PDBid: 1HL3, [162].
occurs, making this position hydrophilic. In the next position the leucine is completely
conserved. In the last position, there is predominance of hydrophilic amino acids, but
two instances of valine is observed. It has been suggested that a lysine residue, fol-
lowed 1-4 amino acids C-terminal to the motif, is involved in regulation of the PxDLS
functional site. Mutational analysis of the viral protein E1A, that mimic acetylation,
where lysine is mutated to glutamine, resulted in proteins that were defective in CtBP
binding [234].
4.4.3 Context rules and filters
Localization. CtBP is localized in the nucleus and is associated with transcriptional
repression. Remarkably, CtBP has also been shown to be involved in tubule fission in
the Golgi. This dual function is proposed to be dependent on the ligand bound to the
CtBP proteins, where CtBP bound to NAD+/NADH is associated with repression in the
4.4. PXDLS 51
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    HDA5_HUMAN/46−70 MGGGGGGSPSPVELRGALVGSVDPT
    IKAR_HUMAN/24−48 PDEGDEPMPIPEDLSTTSGGQQSSK
    TGIF_HUMAN/14−38 ETEDEDSMDIPLDLSSSAGSGKRRR
      Q8IX07/782−806 ARSPGPAADGPIDLSKKPRRPLPGA
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      Q91647/445−469 IILLDSDLDEPIDLRCVKSRCDSDQ
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Figure 4.8: Alignment of proteins listed in table 4.4. Alignment, Weblogo and regular expression
of proteins listed in table 4.4. of all experimentally verified proteins which uses the PxDLS motif in
interaction with the CtBP protein.
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nucleus and CtBP bound to acyl-CoA has a role in the Golgi [222, 162]. Presumably a
CtBP protein bound to acyl-CoA is unable to bind to a PxDLS containing protein, since
PxDLS binding has been shown to be NAD+/NADH dependent. Hence all eukaryotic
proteins that uses the PxDLS motif in interaction with the CtBP proteins seems to be
associated with repression in the nucleus.
Taxonomy. The CtBP proteins have been found in both Mus musculus (mouse),
Homo sapiens (human), Drosophila melanogaster (fruitfly), Xenopus laevis (frog),
Arabidopsis thaliana (mouse-ear cress) and Danio rerio (zebrafish). Although Ara-
bidopsis thaliana does have a CtBP homologue, it is unclear if the protein has PxDLS
binding capability. PxDLS binding activity has been shown for CtBP proteins in
Drosophila melanogaster [177], Xenopus laevis [193], and Homo sapiens [188]. The
taxonomy range for the PxDLS functional site is therefor Metazoa; Taxonomy ID:
33208.
Globular clash filter. There is only one instance where the PxDLS functional site is
found inside a SMART domain. This is in the actin domain (SMART:ACTIN) of mArpα,
but the primary sequence and the occurrence of glycine flanking the functional site
suggests that the functional site resides in a loop of the domain (results not shown).
Molecular context and co-occurrences. Strikingly 18 of the 30 experimentally ver-
ified proteins contain domains that are associated with DNA: 14 proteins contain mul-
tiple Zn-fingers, one protein has a ETS domain (Net), one protein has a homeo domain
(TGIF) and two proteins have a chomo domain (the polycomb homologous; xpoly-
comb and HPc2) . Four of the instances are histone deacetylase type II proteins, mak-
ing 22 of 30 verified instances either with DNA associated domains or proteins with
histone deacetylase activity. The remaining 8 proteins may be adapter proteins (like
CtIP) linking histone deacetylase proteins to other DNA bound proteins.
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Table 4.4: Verified proteins which uses the PxDLS functional site.
Name ID/Acc.nr Short description Length Dom. PMID Ref. Method
CtIP RBB8_HUMAN Retinoblastoma-binding protein 8 898 - 9535825 [189] 3
BKLF KLF3_HUMAN Kruppel-like factor 3 345 - 10756197 [210] 6
KLF8 KLF8_HUMAN Krueppel-like factor 8 359 - 10756197 [215] 1
Fog-1 Q8IX07 Zinc finger protein ZFPM1 1004 - 10995736 [107] 4
Fog-2 Q9UNI5 Zinc finger protein ZFPM2 1151 - 11940669 [107] 6
AML1 EVI1_HUMAN Ecotropic virus integration 1 site protein 1051 - 11965542 [97] 9
Ikaros IKAR_HUMAN DNA-binding protein Ikaros 519 - 10766745 [113] 8
ZFH-1 ZFH1_DROME Zinc finger homeodomain protein 1 1060 - 10359772 [178] 8
Ef1 delta TCF8_HUMAN Transcription factor 8 1124 - 10567582 [71] 2
Tgif TGIF_HUMAN 5’-TG-3’ interacting factor 272 - 10995736 [147] 7
Hairy HAIR_DROME Hairy protein 337 - 9524128 [177] 2
Net ELK3_HUMAN ETS-domain protein Elk-3 407 - 10369679 [48] 2
Knirps KNIR_DROME Zygotic gap protein knirps 429 - 9843507 [108] 4
Rip 140 RI14_HUMAN Nuclear receptor interacting protein 1 1158 - 11509661 [218] 2
HDAC4 HDA4_HUMAN Histone deacetylase 4 1084 - 11022042 [232] 6
HDAC5 HDA5_HUMAN Histone deacetylase 5 1122 - 11022042 [232] 6
HDAC7 Q9JL72 Histone deacetylase 7a 938 - 11022042 [232] 6
MITR HDA9_MOUSE Histone deacetylase 9 588 - 11022042 [232] 3
xpolycomb Q91647 XPolycomb 521 - 9858600 [193] 2
HPc2 CBX4_HUMAN Chromobox protein homolog 4 558 - 9858600 [193] 2
Eos Q9H2S9 Zinc finger transcription factor Eos 483 - 12444977 [174] 2
Trps1 TRPS_HUMAN Zinc finger transcription factor Trps1 1281 - 12449777 [174] 2
ArpN alpha B53B_HUMAN 53 kDa BRG1-associated factor B 426 yes 12565893 [168] 2
LcoR Q96JN0 Hypothetical protein 572 - 12535528 [63] 4
Tramtrack TTKB_DROME Tramtrack protein, beta isoform 643 - 10978285 [224] 7
XTcf-3 P70062 Transcription factor XTCF-3 554 - 10375506 [34] 1
SOX6 SOX6_HUMAN Transcription factor SOX-6 828 - 11504872 [157] 2
HIC1 HIC1_HUMAN Hypermethylated in cancer 1 protein 733 - 12052894 [52] 2
SIP1 SIP1_HUMAN Zinc finger homeobox protein 1b 1214 - 12714599 [213] 4
Viral
Ade. E1A E1A_ADE02 Early E1A 32 kDa protein 289 - 7479821 [188] 4
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4.5 PxVxL
4.5.1 Introduction to HP1 and the PxVxL functional site
The HP1 proteins (heterochromatin protein 1) are non-histone chromosomal proteins
associated with heterochromatin. Heterochromatin is a highly condensed state of chro-
matin associated with silencing of genomic regions. Genes which resides in a het-
rochromatic region are not transcribed and are replicating late. There are two types of
heterochromatin, constitutive and facultative. Constitutive heterochromatin is found at
distinct chromosome territories such as pericentric and telomeric regions. Facultative
heterochromatin is more dynamic and regulated regions where genes can be switched
on and off, depending on e.g. development stages of an organism. In both types of
heterochromatin, the HP1 proteins are central in its formation [46]. The role of HP1
proteins in silencing is thought to be widespread in the genome and the mechanism is
conserved from yeast to man [220].
In mammals, there are three members of the HP1 family: HP1α, HP1β and HP1γ,
consisting of an N-terminal chromo domain [194], a variable hinge region and a C-
terminal chromo shadow domain [2]. The chromo domain in HP1 proteins has been
reported to interact with the N-terminal histone tail in H3 at a specific methylated
lysine residue, K9 [99]. The chromo shadow domain have been shown to bind to a
consensus peptide pentamer, and thereby suggesting that the chromo shadow domain
mediate protein-protein interactions [196]. Further NMR analysis suggested that the
chromo shadow domain forms a homodimer, and a consensus peptide interacts with
an interface defined by the chromo shadow dimer [35]. This was confirmed by a final
NMR analysis of the chromo shadow homodimer bound to a PxVxL peptide [206],
shown in Fig 4.9.
4.5.2 PxVxL containing proteins
Table 4.5. shows all experimentally verified proteins shown to use the PxVxL func-
tional site in interaction with HP1. Common to the proteins is that they are all as-
sociated with DNA, either this is to add the methyl group to the histone tails of the
nucleosomes, like the histone methyltransferase Su(var)3-9 or to initiate transcription
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Figure 4.9: Structure of a PxVxL containing peptide derived from the Chromatin Assembly
Factor 1 protein (CAF-1) bound to a chromo shadow homodimer. The chomo shadow homodimer
(colored white and gray and displayed in cartoon) bound to a PxVxL containing peptide (green cartoon).
The important residues in the peptide are showed in yellow sticks. PDBid: 1S4Z, [206].
* * :
KU70_HUMAN/341−365 DPGLMLMGFKPLVLLKKHHYLRPSL
TF1B_HUMAN/476−500 GEVSGLMRKVPRVSLERLDLDLTAD
SETB_HUMAN/334−358 EEYVTAYPNRPMVLLKSGQLIKTEW
  Q9BMZ9/1041−1065 SPSAVPATTSPLVVLSNQLPLNSVA
TF1A_HUMAN/703−727 PAGADSTHKVPVVMLEPIRIKQENS
CAFA_HUMAN/210−234 AGGILFKGKVPMVVLQDILAVRPPQ
SUV3_DROME/303−327 EAGPEDAQDTPVVMMNGDVDSGDDP
T2D3_HUMAN/752−776 RPPQVTLTQTPMVALRQPHNRIMLT
          Peptide1 YPWVIMR
          Peptide2 
^|
YWPRVIL
          Peptide3 YPYVVLR
          Peptide4 LNPRVIL
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Figure 4.10: Alignment of the verified proteins listed in table 4.5 and peptides from [196]. Four
out of six peptides were included in the true dataset. The remaining 2 peptides were not
included due to large impact on the final regular expression. The Weblogo is made from the
proteins listed in 4.5.
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like that of transcription initiation factor TFIID. Since there are quite few proteins that
have been identified to harbor the site, data from random phage displays obtained by
[196], was included in the final regular expression.
4.5.3 Context rules and filters
Localization. Functional HP1 proteins are presumably always associated with hete-
rochromatin in the nucleus.
Taxonomy. The HP1 is found in all eukaryotes including S. cerevisiae which contain
a HP1-like protein Swi6p [134]. Eukaryota; Taxonomy ID: 2759.
Globular clash filter. There is one clash with a globular domain: In the KU70 pro-
tein from human (SMART:Ku78). By investigating the structure of the domain and
where the functional site resides, suggests that this site is most likely accessible (re-
sults not shown).
Co-occurrence and molecular context. There are no co-occurrences of domains or
other functional sites that can be associated with the PxVxL functional site. Although
all proteins which contain the functional site, no surprisingly, have however domains
that are associated with chromatin including Zn fingers, a SAP domain and a Bromo
domain.
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Table 4.5: Verified proteins containing the PxVxL motif.
Name ID/Acc.nr. Short description Length Dom. PMID Ref. Method
CAF-1 CAFA_HUMAN Chromatin assembly factor 1 subunit A 938 - 10549285 [158] 4
TiF1 alpha TF1A_HUMAN Transcription intermediary factor 1-alpha 1050 - 10562550 [163] 1
TiF1 beta TF1B_HUMAN Transcription intermediary factor 1-beta 835 - 10938122 [121] 4
Su(var)3-7 SUV3_DROME Suppressor of variegation protein 3-7 1169 - 12163401 [100] 10
SETDB1 SETB_HUMAN Histone-lysine N-methyltransferase 1291 - 11959841 [191] 6
TAFii130 T2D3_HUMAN Transcription initiation factor TFIID subunit 4 1083 yes* 11959914 [217] 4
AF-10 Q9BMZ9 AF10 1376 - 11266362 [129] 1
Ku70 KU70_HUMAN ATP-dependent DNA helicase II, 70 kDa subunit 608 yes 11112778 [197] 1
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Table 4.6: Statistics of the regular expressions.
Swiss-Prot Human
Total hits Hits per protein Total hits Hits per protein
LIG_RB 13887 0.09 4636 0.16
LIG_SID’s 1533 0.01 431 0.01
LIG_CYCLIN 352194 2.3 87569 3
LIG_CtBP 22687 0.15 5937 0.2
LIG_HP1 2610 0.02 625 0.02
4.6 Attributes of the regular expressions
To get some sense of how each regular expression behave when exposed to protein
sequences, searches in two different databases were performed: Swiss-Prot and a hu-
man database, see table 4.63. An interesting observation is that the number of hits pr.
protein in the human database increases when compared to hits pr. protein in Swiss-
Prot. This may be due to human proteins are longer then the average Swiss-Prot entry.
Note that these hits where not subject to filtering. See section 5.2 for discussion of
predictive power of the ELM resource and demonstration of filtering.
4.7 New functional sites
During the siteseeing process and the browsing a large amount of literature, several
new functional sites were identified. Some of these were annotated by a ELM consor-
tium member or they await further analysis. These functional sites are listed in table
4.7.
3Searches done in Swiss-Prot release 43.0, consisting of 148516 annotated entries. A non-redundant
human proteins annotated with “Homo sapiens” in UniProt, a total of 28814 annotated entries obtained
from http://www.ebi.ac.uk/proteome/HUMAN/download.html. LIG_SID’s is the sum of hits from the
three regular expressions representing the SID functional site.
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Table 4.7: Functional sites identified in the literature during siteseeing.
Name Description Ref. Status ELM ID
EEVD TRP binding motif [69] annotated LIG_TPR
PxDLS CtBP binding motif [188] annotated LIG_CtBP
YPWM PBX binding motif [195] annotated LIG_HOMEOBOX
FxxxWxxL MDM2 binding motif [211] annotated LIG_MDM2
YXXQ STAT3 binding motif [151] not annotated
HPQ Streptavidin binding motif [119] not annotated
AB U1 snRPN 70K binding motif [116] not annotated
LDSF SAGA binding motif [144] not annotated
S100B S100B binding motif [95] not annotated
LxL MAP kinase binding site [90] not annotated
MEFS MEF2 binding site [82] not annotated
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Chapter 5
Discussion
During this work I have annotated five functional sites in the ELM database. In this
process several issues were encountered and are discussed below. The current status
of the ELM resource and future challenges are also discussed.
5.1 The Siteseeing process
Collecting instances. The siteseeing process starts with a seed paper, often a pub-
lication describing the structure of a functional site bound to recognition module or
a good review. These seed publications guide the siteseer further into the literature.
Ideally all references which describes a particular functional site are collected, but this
can be time consuming and not trivial, since the literature can vary in quantity and
focus. Performing text searches in PubMed and retrieving useful information is, to
some extent, an intuitive process. To make a successful search, the query should be
a combination of good keywords which describes the wanted information. Defining
these keywords is the often the hardest part, but becomes easier with experience. The
same can be said about doing good Google searches.
Handling the information. When collecting instances and storing it, in the form of
pdf documents, sequence files and alignments, requires some form of structure and
discipline. Making a local database is convenient but not necessary. There are two
different strategies in siteseeing and annotation of the data: continuous or batch site-
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seeing/annotation. Continuous siteseeing means that collecting data progresses slowly
over time, and allow parallel analysis of several functional sites. While batch sitesee-
ing is more intensive and focuses only one functional site at the time. In this thesis,
the siteseeing process have been continuous and slow while the annotation into the
ELM database have been more batch oriented, where the accumulated data have been
quickly annotated.
Expanding by homology. All sequences, paralogs and orthologs could be included
in the true positive dataset. A candidate motif in a homologue protein should share
some degree of similarity of the motif with the verified protein. When including par-
alogs however, there is the risk of including false positives. Orthologs in closely related
species, like human and mouse, share many of the same molecular mechanisms, but
in more distant related species like human and fly, this may often not be the case. It is
possible that orthologous recognition modules have diverged, which a corresponding
divergence in the orthologous functional site. This will result in a poorer regular ex-
pression, which may identify the putative functional site in another species, but at the
expense of the regular expression being more relaxed. There is also a limited amount of
time a siteseer can use in siteseeing. Collecting orthologs of e.g. 20 verified instances
of a functional site is a laborious task. This is primarily due to the large workload re-
quired and the difficulty in deciding which proteins are orthologous and which are not.
A standardized automated system for expanding the true positive dataset by orthology
which uses criteria such as trusted taxonomic ranges and fixed cutoff values would be
very useful.
Evolving databases. Every protein listed as verified instances in the tables in Chap-
ter 4 have a Swiss-Prot or TrEMBL id or accession number. Since these protein
databases are continuously evolving and are subject to change, some of these id or
accession numbers are already or may become invalid. This may be a problem since
the annotated information may have been outdated and therefore useless. A possible
solution is to make sure that the annotated instances in the ELM resource are automat-
ically compared with the respective databases.
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Data from viruses. Several pathogenic organisms have evolved functional sites in
their proteins to interact with recognition modules in the cell, often with the intention
to manipulate the cell in achieving something favorable for the virus. Such proteins
have been included.
Evaluating experimental evidence. This is probably one of the most difficult parts
in annotating functional sites into the ELM database. One would expect that all data in
a publication have been subject to thorough examination of the authors and referees.
There are, however, several scenarios where the data in a publication could be con-
sidered as questionable. Consider the following hypothetical example: a publication
is investigating an interaction between two proteins and suspects that this interaction
is mediated by a functional site in one of the proteins. A yeast-two hybrid system
confirm the interaction. Several truncated mutants are produced in order to narrow
down to a responsible subsequence. A single subsequence in one of the truncated pro-
teins reveals a consensus motif for a functional site which is well known to mediate
this protein-protein interaction. Therefor the publication concludes that this protein-
protein interaction is mediated by this functional site. Should this be considered a veri-
fied functional site? This depends on the impact the publication has on the true dataset
and the final regular expression. If a publication is considered as containing weak evi-
dence, the information is only included if the publication has no or small impact on the
regular expression. A large impact would be to alter a very important position e.g. the
completely conserved leucine in the RxL motif, to be more relaxed e.g. to also allow
the unrelated amino acid residue glutamate. Take the LxCxE functional site as an ex-
ample: 25 proteins have been confirmed to contain the LxCxE functional site, among
these 23 have the consensus LxCxE, while one has LxCxD and one has IxCxE. The
impact of these two divergent motifs is quite large but are included due to chemical
similarity and the regular expression [LI].C.[DE] do not overpredict too severely. It
is the consequences for including weak data that should be considered. In this thesis
data from almost all collected publications are included. If a publication suggests that
a functional site is present without experimental support e.g. by altering the motif, this
is not included.
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Some studies uses viral vectors such as random page displays when investigating a
functional site e.g. [183]. Undoubtedly useful, some of these data may be artificial and
may not represent an in vivo situation. Data from experiments such as phage displays
are only included when there are few instances of “real” proteins.
Making the regular expression. The regular expression is probably one of the most
important results of the siteseeing process. There are some different views in the ELM
consortium of what the regular expression should reflect: the verified instances or the
molecular properties of the functional site. The regular expressions in this thesis pri-
marily reflect the verified instances, and not always the biochemical properties of the
positions. The main reason for this is that functional sites overpredict, and including
none observed data will sometimes contribute to higher overprediction. In making
regular expressions there are two different ways in including none observed data: ex-
cluding and including rules. Excluding rules like “not proline” in a helix, will enhance
the performance of the pattern. But “leucine is observed, so why not isoleucine?” is
inclusive, and will make the pattern more relaxed. A siteseers dilemma is to weight
the predictive power by the pattern versus the molecular properties of the positions.
Take the functional site PxDLS as an example, see section 4.4. The functional
site has been observed in 30 proteins. In the first position 28 of have a proline, but
two have glycine. Should this first position be a [P] or a [PG]? The properties of
proline and glycine are quite different, but should this, alone, be enough to ignore
two publications which shows that glycine can indeed occur at this position? In this
thesis all publications describing a functional site occurrence have been included in
the true dataset and hence influence the regular expression. In this example there may
be indeed a preference for having a proline at this position (or may just be biased).
This knowledge are lost in the regular expression where proline and glycine are equal
weighted. A more sophisticated detection method, like PSSM, may thus perform better
then regular expressions. Adding to this problem is the fact that all instances of a
particular functional site may have different affinities for its corresponding recognition
module, which is reflected in the diversity of the sequence.
A regular expression should be under continuous development in regard to the
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Table 5.1: Development of the final regular expression for the RxL functional site.
Hits pr. human protein in Swiss-Prot Fraction of TP from Fig. 4.6
R.L 3,2 16/20
[RK].L 6,3 20/20
[RK].L.{0,1}[FYLIVMP] 3,3 20/20
amount of data collected and advances reported in the scientific literature. A good
example of the development of a regular expression is the RxL functional site (see
Table 5.1). The regular expression started out as R.L (the name of the motif is RxL).
Further investigation in the literature and alignment showed that the regular expression:
[RK].L was more representative. More related structural information showed that a
hydrophobic residue after the [RK].L motif also contributed to the interaction [135],
and was thereby included in the final regular expression, [RK].L.{0,1}[FYLIVMP].
Often the consensus sequence in the literature (here RxL), only reflect a subset of data,
and sequence and data analysis is important in making the pattern represent all verified
instances.
Aspects of regular expressions. The major strength of regular expressions is that
they are fast and easy to generate manually. This means that an expert can easily de-
scribe a functional site with a regular expression. Another positive thing about regular
expressions is that they are easy to read and interpret in terms of biological concepts
like essential residues or biochemical nature of the functional site or in the cognate
recognition module. The major drawback is that they are binary in nature; either a pat-
tern matches or it does not. This nature of patterns makes it difficult to rate and score
the matches in order to find sequence similarities. It is very important that a regular
expression is made carefully in respect to the rules that are applied. Therefore the data
which a regular expression is derived from, should be of high quality.
In bioinformatics it is common to talk about the diagnostic power of a sequence
analysis method. This diagnostic power is divided into two measurements: specificity
and sensitivity. The most specific search returns only true matches. The most sensi-
tive search returns all true positives. It is desirable to have high values for both (for
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TN
All sequences
TP
All matches (TP+FP)
FN
[LI].C.[DE]
All sequences
TP
FN
All matches (TP+FP)
TN
[RK].L.{0,1}[FYLVIMP]
Meaning
TP True and detected Recovery of proteins in true dataset
FP False and detected Recovery of false proteins
TN False and not detected Loss of false proteins
FN True and not detected Loss of proteins in true dataset
Figure 5.1: A graphical representation of how the regular expressions [LI].C.[DE] and
[RK].L.{0,1}[FYLVIMP] behaves. The TP are most of the true positives listed in table 4.1 and
4.3. The FN are true proteins from table 4.1 which are lost due to missing annotations in Swiss-Prot. The
TN are all other sequences which does not match the regular expression.
a more extensive overview, see [94]). Calculating the values of sensitivity and speci-
ficity implies that the numbers of TP, FP, FN and TN are known (see Fig 5.1). When
investigating a well known protein family this may be determined, but is far more dif-
ficult when the proteins are unrelated and share little sequence similarity. Take the
regular expression [LI].C.[DE] from the functional site LxCxE as an example. From
table 4.6, this regular expression has 13887 matches in Swiss-Prot. Approximately 20
of these are true positives (from table 4.1). Does this mean that the remaining 13867,
are false positives? Probably not, since one would expect that all proteins which have
the functional site are not experimentally verified yet. Since the regular expression is
derived from, and matches all true positives, one would expect that the regular expres-
sion has a very high sensitivity (detects all true proteins) and have a low specificity (the
true proteins are a minor fraction of the returned results). Sensitivity of the LxCxE site:
TP/(TP+FN) = 20/(20+0) = 1. Specificity: TP/(TP+FP) = 20/(20+(13887-20) = 0,001.
One would expect that most regular expressions describing functional sites behaves in
this manner, but there are exceptions. One of these exceptions is the WRPW functional
site (ELM:LIG_WRPW_1) which is a Groucho ligand [66]. Sensitivity = 33/(33+0) = 1.
Specificity = 33/(33+21) = 0,6. Data taken from [180].
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5.2 Aspects of functional sites
Aspects of functional sites. Functional sites are involved in many different types of
molecular and biological processes, so it is difficult to make general statements regard-
ing all functional sites. The ELM consortium have divided functional sites into four
different classes: ligand, modification, cleavage and target sites. The ligands, as seen
in this thesis, are important in mediating protein-protein interactions. Protein-protein
interactions can be divided into two categories: globular domain-globular domain in-
teractions and functional site-globular domain interactions. Functional site-globular
domain interactions are thought to be short lived and transient, in contrast to more
long lived protein complexes which are held together with globular domain-globular
domain interactions. The five functional sites in this thesis mediates interactions be-
tween proteins to perform something to the nearby surroundings, either this is to in-
crease the time spent in the proximity of cyclin/CDK hetrodimer or to recruit proteins
with deacetylases chromatin and repress transcription. These ligand sites may allow
the rapid development of novel protein-protein interactions and hence increase the
connectivity between proteins.
One would think that all proteins are subject to one or more post-translational
modifications during their lifetime, and therefore contain modification functional sites.
Modification sites are obviously a prerequisite for the attachment of another molecule
to a protein. The abundance of different functional sites which acts as modifica-
tion sites, are reflected in the sheer number of different types of post-translational
modifications which are known. At present, more than 200 different types of post-
translational modifications are known including: phosphorylation, acetylation, glyco-
sylation, methylation, sulfation and ubiquitination. It is also predicted that each hu-
man gene, on average, may produce three functionally different proteins as the result
of post-translational modifications [24]. An abundant post-translational modification
is phosphorylation, which 30% of all proteins are thought to be subject to during their
functional life cycle [65]. Modification sites are regulatory determinants allowing a
more dynamic behavior of proteins and expanding the functional space of amino acids
and ultimately proteins.
Ligand and modification sites cooperate, in some cases, to define a molecular prop-
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erty of a protein. This is seen in the p53 protein, see Figure 1.4. p53 has several
ligand functional sites that interacts directly or indirectly with an enzyme and presum-
ably increases the modification level of the protein. These ligand sites are here called
substrate recognition sites. Substrate recognition sites in p53 are: ELM:LIG_CYCLIN
(phosphorylation by CDK), ELM:LIG_MDM2 (ubiquitination by MDM2), LIG_p300
(acetylation by p300) and LIG_CBP (acetylation by CBP). Some other substrate recog-
nition sites not found in p53 but in several other proteins include LIG_MAPK (MAP
Kinase recognition site) [25], ELM:LIG_SH3 and ELM:LIG_SH2 (Src Homology 2 & 3
site) [192]. These substrate recognition sites may be a common mechanism to deter-
mine which proteins are modified and by who.
Many functional sites are also regulated in the same manner as domains by post-
translational modifications, which is not surprising since important functions reside in
them. Two examples of regulated functional sites is the acetylation of a nearby lysine
residue of the PxDLS site [234] (see section 4.4.2) and the competing functional sites
in the C-terminal region in p53 (see Figure 1.4). By looking at this figure p53 has
stunning many functional sites. Since functional sites are recognized by domains, the
number of different functional sites can not exceed the number of different globular do-
mains. But instead the frequency of functional sites are thought to greatly outnumber
the frequency of globular domains in individual proteins.
How do functional sites arise? As mentioned earlier, functional sites constitutes
a major class of functional units, as seen with Src and p53 (see Fig. 1.3 and 1.4).
Functional sites are a diverse group and may originate by different evolutionary mech-
anisms. Since functional sites are so short and occur mostly in non-globular regions, it
may be possible that a handful of single point mutations at specific positions may lead
to the spontaneous formation of a functional site. The prerequisites for a functional site
to arise can be: 1) the presence of a globular domain which is able to act as a recog-
nition module. 2) the host protein share some common cellular context as the protein
containing the recognition module. 3) the cell benefits the functional site-recognition
module interaction.
Other functional sites which are associated with an co-occurrence may share the
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*
Time Duplication Divergence
Figure 5.2: A possible scenario for the development of a functional site. First, on the far
left, the origin of a recognition module which is able to interact with a functional site in a host
protein. This mechanism is kept and over time and a new functional site spontaneously arise
in a similar protein. After a duplication event of the recognition module, result in two proteins
which are able to interact with the functional site containing proteins. Due to divergence,
the two recognition modules develop into two slightly different modules, recognizing slightly
different functional sites.
same evolutionary events as the co-occurrence. One example of this is the functional
site YPWM, which is always found together with a homeo domain (SMART:HOX). The
role of this functional site is to interact with another homeo domain found in the PBX
protein, to increase the DNA binding affinity of the protein containing the functional
site [202]. It may be possible that this functional site share, to some extent, the same
evolutionary history of the homeo domain or may simply be a “satellite” part of the
homeo domain.
All proteins recognizing functional sites in this thesis exist in more then one vari-
ant in human cells. This is the result of gene duplication that are though to be quite
common, especially in humans compared to yeast, worm and fly [120]. This gives
rise to the possibility that there may be a slight difference in selectivity of the recogni-
tion modules which is reflected in the diversity of subsequences which can be seen in
Chapter 4. This possible difference in selectivity may be the result of divergence of the
recognition modules which also forces a change in the cognate functional site. This is
highly speculative, but interesting prospect. See Fig 5.2, for a schematic overview of
a possible evolutionary scenario.
Changes in non-globular regions are more prone to genetic change and are more
likely to be tolerated over time, in contrast to domains, due to their "structureless"
and presumably passive nature [36]. These non-globular regions in proteins may act
as a “dead subsequences” or a kind of evolutionary buffer-zone, where changes are
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tolerated and a novel modification site, a protein-protein interaction site or a domain
insertion may arise. It should also be mentioned that these non-globular regions may
not have any apparent function, like containing functional sites, but instead act as
flexible regions which are needed to separate different protein units in space. For
example separate the two functional sites ELM:MOD_CDK and ELM:LIG_CYCLIN, which
require a region of 12 amino acids between them to be functional [204].
What is the expected frequency of occurrence of a functional site? Consider the
following hypothetical protein: A protein composed of 500 amino acids and several
domains and non-globular regions. ~ 300 amino acids defines domains and the remain-
ing ~200 amino acids reside in non-globular regions. What is the expected frequency
for a functional site to occur by pure chance in the non-globular region? Take the
LxCxE functional site as an example1: calculating the expected frequency of regu-
lar expression [LI].C.[DE]. Calculation is done by using the observed frequency of
amino acids in Drosophila melanogaster 2. The expected frequency of the pattern
is 3x10-4. The expected frequency for the 200 amino acids containing the LxCxE
site is therefore = 3x10-4 x 196 (since the regular expression can occur at 196 differ-
ent positions) = 0,058. This leads to an interesting question: How many Drosophila
proteins can we expect to contain the LxCxE functional site? 17237 proteins in a non-
redundant Drosophila proteome3 with a presumed average length of 300, results in:
3x10-4 x (17237 x 296) = 1530 proteins. Interestingly a search with the regular ex-
pression in Drosophila proteome reveals 2780 hits with the regular expression. Since
the observed frequency is much higher then the expected frequency, the regular expres-
sion [LI].C.[DE] is not just a combination of amino acid residues, but has indeed a
biological significance.
Another example of a regular expression with biological significance is a homeo
domain ligand (ELM:LIG_HOMEOBOX). The regular expression is [FY][DEP]WM and
have an expected frequency of 2,5x10-7. The expected frequency of occurrence in
the Drosophila dataset is 1,46. While the observed value is 65. By this approach
1Here a questionable assumption is being made: that all amino acids occur uniformly in the protein
sequence. There may be additional reasons for a cystine of flanked by a hydrophobic amino acids in the
N-terminal and an acidic amino acid C-terminally. E.g. in a particular globular domain.
2Data from: http://www.ebi.ac.uk/proteome/DROME/structure/drome_7227_amino.html
3Obtained from: ftp://ftp.ebi.ac.uk/pub/databases/SPproteomes//fasta_files/proteomes/7227.FASTAC
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it may be possible to discover new functional sites based upon the difference in ex-
pected frequency versus the observed frequency. Unfortunately however, most regular
expressions describing functional sites does not show this difference in observed and
expected values.
Network of the five functional sites. All collected proteins in this thesis were used
to make a network with Biolayout [62]. This thesis focuses on a limited number of nu-
clear processes in particular transcriptional repression and may not be surprising, but
instead encouraging, to see that different functional sites involved in separate protein-
protein interactions, form a interconnecting network. There are several interconnecting
proteins which brings one network together with another network. One of these pro-
teins is the CtIP protein that connects the Rb and CtBP network, see figure 5.2. This
is already known [148], but by constructing these kind of networks novel mechanisms
and relations may be discovered. These interconnecting proteins may show that func-
tional sites are able to bring functional networks together. As mentioned, ligand func-
tional sites allow a rapid mechanism for not only to increase the connectivity between
single proteins, but whole networks. There are six protein-protein interactions in the
lower picture in figure 5.2: Three globular domain-globular domain interactions (E2F-
DP, E2F-Rb and CtBP-CtBP) and three functional site-globular domain interactions
(Rb-CtIP, CtIP-CtBP and CtBP-HDAC). This may suggest that functional site-domain
interactions may be as common as globular domain-globular domain interactions.
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HDAC
CtIP
E2FDP
Rb network
CtBP network
CtBP
CtBP
Rb
Figure 5.3: Network of all proteins in this thesis. Top: picture showing all interactions which
involves the five functional sites analyzed here. All proteins that has a recognition module are colored
blue. All proteins that contain a functional site are colored as followed: RxL=purple, LxCxE=yellow,
PxVxL=green, PxDLS=red and SID=light blue. Bottom: the interconnecting protein CtIP which brings
the Rb and CtBP network together via two different functional sites.
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5.3 The ELM resource
This is a small summary of the current status and future challenges for the ELM re-
source from a siteseers perspective.
Current status. At present, there are 91 functional sites represented as 116 different
patterns. The ELM resource represent the largest collection of data regarding func-
tional sites, and there are additional ~30 functional sites which awaits siteseeing. The
usage of the resource is shown in Figure 5.2.
Figure 5.4: The usage for the ELM resource. The development of monthly number of hits for the
ELM resource (http://elm.eu.org/usage.html).
Does the ELM resource work ? To what extent does the ELM resource reflect the
real occurrence of functional sites in a protein? To investigate this question, a well
studied protein with many experimentally verified functional sites was selected: the
p53 protein from human (see section 1.1.1 for more details). p53 was subjected to
superficial siteseeing, and the results are shown in Figure 1.4. Ten out of 36 experi-
mentally verified functional sites, or 27%, are predicted by the ELM resource (seven
of these are phosphorylation sites in phosphoELM, http://phospho.elm.eu.org/). This
shows that many different functional sites await analysis and annotation into the ELM
resource. It should be noted that all functional sites may not have been registered in
this survey.
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Table 5.2: Filtering removes many candidate proteins. Swiss-Prot 40.41 (121515 sequences) where
subjected to searches with regular expressions from three functional sites and subsequently filtering of
the hits. Context filters are: taxonomic distribution and sub-cellular localization. All three functional
sites are found in the nucleus of metazoan species. Data from [180].
Total Hits Taxonomy Subcellular localization Fold reduction
LIG_WRPW 54 42 34 1,5
LIG_RB 6127 2784 484 12
LIG_NRBOX 44902 19963 2003 22
In section 1.2.1, the concept of filtering was explained. Table 5.3 shows that applying
context information indeed removes a lot of candidate proteins. It should be
mentioned that presumably some true positives are removed as well due to several
factors: missing annotation in Swiss-Prot or the regular expression does not match all
true positives.
Predictive power. The predictive power of the ELM resource ranges from very poor
to very good, depending on the annotated functional site and its regular expression. An
example of a site with very poor predictive value, is a ligand site to the PDZ domain,
which has a higher frequency of occurrence then the amino acid trypthophan. Another
site which overpredicts massively is the RxL functional site described in section 4.3
and have 3 hits pr. human protein, see table 4.6. On the other hand some functional
sites, like the ligand to the Groucho protein, has a very high degree of confidence and
most hits are to be considered true [180]. This does not mean the respective siteseers
do a better job then the other, but rather that some functional sites are intrinsically very
difficult to describe in respect to a regular expression. This means that most matches
shown are more likely to be false positives than true matches. ELM predictions should
therefore not be treated as factual findings, but instead provide useful information in
experimentation. Hopefully further improvements of different filters will strengthen
credibility of predictions. In addition to predict functional sites in proteins, ELM is
a resource where users can browse and read about a functional site in their interest.
This makes the ELM resource a valuable library for retrieving information regarding
functional sites and guiding a user further into the scientific literature.
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Table 5.3: Recent ELM instances reported in the scientific literature.
Functional site Protein Detected by ELM? Ref.
LxCxE WDW RepA yes [79]
RxL Axin yes [111]
Orc6 yes [226]
PxDLS Smad6 yes [128]
Recent ELM instances. New verified ELM instances are frequently reported in the
literature. To investigate how many new ELM instances have been reported since this
work was considered finished (autumn 2003), are listed in table 5.2. The proteins in
table 5.2 have not been influencing the annotated regular expression for each respective
functional site. Interestingly, all four proteins are detected by the ELM resource.
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5.4 Conclusions
Five functional sites were annotated into the ELM resource according to aims i), ii)
and iii). Aim iv) is listed in table 4.6.
Functional sites is a diverse and functionally important category of protein units.
This work has been a small contribution in making a needed database which can give
more attention to these protein units.
Many questions remains to further investigated regarding functional sites. Some of
these may be the evolution of functional sites and their cognate recognition modules.
The observation that many ligand functional sites act as substrate recognition sites in
post-translational modifications is also very interesting.
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5.5 Future work
Many functional sites await annotation in the ELM resource as seen in table 4.6. When
annotating this kind of information, development and further advances in the literature
requires that the annotated information is continuously updated. This poses a ma-
jor challenge for the ELM resource. Although filtering removes predictions by many
orders of magnitudes, not surprisingly, overprediction is still a problem. The main
reason for this is that some regular expressions are extremely short and unspecific.
This simply means that some functional sites are very short, but are indeed recognized
by proteins in the cell. Obviously the cell knows how to recognize these sites and
may include information like a more detailed sub-cellular localization and timing the
expression of relevant proteins. But we only have a protein sequence and some con-
textual information. Exploring and understanding the contextual information further
will hopefully lead to the implementation of more detailed rules and filters. Some
functional sites may simply be composed of one residue e.g. cleavage sites in proteins
recognized by trypsin, which cleaves exclusively C-terminal to arginine and lysine
residues [167]. Doing prediction of such a functional site is meaningless, but not if
detailed contextual information are associated with the site such as: co-occurrence of
functional units, expression data or molecular accessibility in terms of disorder. Maybe
a more detailed sub-cellular localization information or protein complex information
could provide applicable context filters. More detailed sub-cellular localizations in the
nucleus could be the nucleolus, nuclear lamina, PML body or PcG body [200].
To enhance the predictive power of the ELM resource several filters are considered
to be implemented. Most of these filters are structural filters, meaning they use struc-
tural information and sequence analysis the determine if a predicted functional site
is accessible and hence functional. One of these filters is GlobPlot, which measures
globularity and disorder of protein sequences [130]. A potential filter is applying ob-
served relationships between protein units which are associated with a functional site,
e.g. the ELM:LIG_CYCLIN and ELM:MOD_CDK are associated with one another as a log-
ical rule, see section 4.3.3. Another example of a co-occurrence is the functional site
ELM:LIG_HOMEOBOX which is always observed with a homeo domain (SMART:HOX) in
several Hox proteins [202]. Another possible filter is to include protein expression data
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in different cell types e.g. micro array data or annotated information from databases
e.g. GXD (Mouse Gene Expression Database) [89], to discriminate between relevant
predictions. For example: protein A, interacts with proteins B and C, but these two
proteins: A and B, are not found simultaneously in a cell.
Context information about proteins, as applied in the ELM resource, could also
be used in other online resources, like protein-protein interaction databases. Many
of these databases, including MINT [231] and IntAct [87], stores binary interaction
data. Although very useful in investigating a single protein-protein interaction, these
resources does to a lesser extent, provide an actual picture of a biological situation.
Patterns is the most used method in detecting or searching for functional sites in
protein sequences, but there exists alternatives. Meta-MEME is software tool based
upon HMM models, where the focus is on strengthening statistical methods in detect-
ing short sequences [77]. Meta-MEME builds a HMM profile based upon a MEME
output format [20]. Meta-MEME is not used here, but could provide a better detec-
tion method than patterns, especially in regard to scoring hits. Another alternative are
PSSM [86], and its application in ELM is being investigated. Due to emphasis on con-
text information and not sequence detection methods, this in not investigated further
in this thesis.
Currently there are nomenclature of four different classes of functional sites in
the resource: ligand (LIG), modification (MOD), cleavage (CLV) and target (TRG,
which is actually a ligand). This has show itself to be to simplistic. Several additional
classes should be added like the isomerization (ISO & ISO_MOD) and ligand modi-
fied (LIG_MOD). An example of an ISO_MOD, is the propyl isomerase PIN1, which
recognizes a phosphorylated serine/threonine and isomesmerizes the downstream pro-
line (pS/T-P) in for instance p53, see Figure 5.3. A LIG_MOD could be the 14-3-3
proteins which recognizes and binds a phosphorylated serine/threonine and neighbor-
ing sequences [182]. One could even imagine a CLV_MOD, where a subsequence is
tagged for cleavage. The problem with an event which follow after a modification, are
that modification information is not implemented in standard sequence formats. One
possibility is to make additional rules to an existing format like FASTA. For example a
modified residue is marked with parenthesis and an additional letter or word is given to
5.5. FUTURE WORK 79
the residue, like an acetylated lysine in the sequence ASKL then becomes AS(acK)L,
or a phosphorylated serine in the same sequence, A(pS)KL.
Hopefully some experimental studies will be performed in the future based upon
the predictions of the ELM resource and the functional sites described in this thesis.
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Appendix
Algorithm 1 getseq python code. Used for online retrieval of protein sequences.
#!/usr/bin/python2.2
#
# getseq [ Accession, entry name ]
#
# Author Morten Mattingsdal
import os,sys
from Bio.WWW import ExPASy
try:
ids = [sys.argv[1]]
except:
print "\n getseq [id/acc.nr]\n"
raise SystemExit
all_results = ’’
for id in ids:
results = ExPASy.get_sprot_raw(id)
all_results = all_results + results.read()
from Bio.SwissProt import SProt
from Bio import File
s_parser = SProt.RecordParser()
s_iterator = SProt.Iterator(File.StringHandle(all_results), s_parser)
while 1:
cur_record = s_iterator.next()
if cur_record is None:
break
print ">" + cur_record.entry_name + "\n" + cur_record.sequence + "\n"
print "length", cur_record.sequence_length
print
